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Abstract 
The purpose of this thesis was to examine the role of orally ingested protein and branched 
chain amino acids (BCAA) in exercise recovery. The use of nutritional interventions to aid 
recovery from multiple lengthening contractions has received a considerable amount of 
attention. Specifically, investigations have focussed on the efficacy of protein and amino acid 
ingestion on exercise recovery, although the results of these studies are conflicting. Equivocal 
findings may be attributed to several discrepancies in study design and lack of adequate 
dietary control. Two studies included in this thesis were designed to examine the effect of 
ingesting amino acids following an intense bout of multiple lengthening contractions of the 
quadriceps muscle in untrained males. Ingestion of BCAA (chapter 2) resulted in decreased 
muscle soreness. Moreover, ingestion of whey protein isolate (chapter 3) resulted in reduced 
muscle soreness and a reduction in the decrement of superimposed electrically stimulated 
maximal force production. The exercise protocol was replicated in both studies to facilitate 
comparison between whey protein and BCAA ingestion. Furthermore, strict dietary control 
was implemented as an integral part of the study design. Our results suggest that ingestion of 
all amino acids are required to reduce decrements of maximal force production associated 
with intense lengthening contractions, whereas ingestion of only the BCAA results in 
decreased muscle soreness. 
The importance of protein feeding for maximising the anabolic effect of resistance exercise 
is well established. Ingestion of essential amino acids or intact protein sources during exercise 
recovery further stimulates muscle protein synthesis. Signalling proteins within the muscle 
influence the translation of messenger RNA and therefore muscle protein synthesis. It has 
been demonstrated in rodents and humans that ingestion of only BCAA leads to an altered 
phosphorylation status of signalling proteins. However, the effect on muscle protein synthesis 
  ii 
of ingesting only BCAA has not been investigated. This thesis demonstrates that following an 
acute bout of resistance exercise in the fed state, ingestion of BCAA resulted in a 22% 
increase in muscle protein synthesis (chapter 4). These results suggest that only the ingestion 
of BCAA is required to augment the response of muscle protein synthesis to resistance 
exercise. 
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Muscle protein metabolism during and after exercise and feeding is a popular topic in 
which there has been a plethora of research. Muscle contains ~40 % of the total protein in an 
adult male body and accounts for 25-30% of  whole body protein turnover. Protein consists of 
individual amino acids joined by peptide bonds. Amino acids can be subdivided into essential 
amino acids (EAA) or indispensible amino acids, and non essential amino acids (NEAA) or 
dispensable amino acids. Unlike NEAA, ESS cannot be synthesised by the human body, and 
must, therefore, be consumed in the diet. The branched chain amino acids (BCAA), leucine, 
isoleucine and valine are three EAA that can be oxidised within skeletal muscle. Currently it 
is the BCAA that are thought to be the most important for muscle protein synthesis and in 
exercise recovery. 
 
1.1 Muscle damage 
 
1.1.1 Mechanisms proposed to cause lengthening contraction induced muscle damage 
Skeletal muscle consists of both contractile and structural proteins, either of which may 
become damaged during unaccustomed lengthening contractions. Although the mechanisms 
behind lengthening induced muscle damage are yet to be fully elucidated, it is purported that 
there are 3 separate phases (8). It has been suggested that following lengthening contractions 
normal sarcomeres become disrupted due to overstretching leading to membrane damage, 
resulting in local contracture and then fibre death (115).  
1.1.1.1 Initial phase of lengthening contraction induced muscle damage 
During exercise, the mechanical stress from lengthening contractions stretch the myofibrils 
and sarcomeres within each muscle fibre (98). This leads to z line streaming, regional 
disorganisation of myofibrils, damage to t-tubules and loss of membrane integrity (115, 124). 
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The popping sarcomere hypothesis (103) suggests that the non-uniform stretching of 
sarcomeres results in the muscle being stretched beyond optimum length. The overstretched 
sarcomeres become progressively weaker until they reach their yield point, when they 
lengthen rapidly until there is little or no overlap between the myofilaments (51). This 
overstretching of sarcomeres occurs at random and is therefore distributed across the muscle 
fibre. Such non-uniform lengthening promotes shearing of the myofibrils, which may results 
in exposure of internal cell membranes, especially t-tubules and a disturbance in the 
intracellular calcium ion (Cai) homeostasis. When the muscle relaxes the majority of the 
overstretched sarcomeres re-interdigitate enabling normal function (127). However, a few 
myofilaments will not re-interdigitate and so become permanently disrupted.  
Disruption to sarcomeres can occur during the muscular contraction or relaxation, which 
influences the localisation of muscle damage. If the muscle is overstretched when actin and 
myosin are bound together, these contractile proteins become damaged and an increase in 
plasma concentrations of other proteins associated with actin (e.g troponin I) (120) and 
myosin (myosin heavy chain) (121) are observed. If the overstretching of sarcomeres occurs 
when actin and myosin are disassociated, tension of the overstretched sarcomeres may be 
transferred to cyoskeletal proteins (e.g desmin and titin) causing disruption to the structure of 
the myfibrils (127). Damage to titin, the elastic filament that secures the thick myosin 
filament to the Z line, may cause the next sarcomere to overstretch, thus propagating damage 
longitudinally (1). Desmin may be damaged by excessive forces early in exercise (90) and 
may cause the damage to spread laterally. Damage to the sarcoplasmic reticulum, transverse 
tubules or sarcolemma can occur if the longitudinal and lateral damage spreads to the adjacent 
areas of the muscle (1).  
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Damage to the sarcomeres can lead to problems with excitation-contraction coupling, 
thereby impairing the generation of force. If the cell membrane is disturbed there is leaking of 
some proteins into the extracellular space and eventually the circulation. Consequently, 
increased levels of these proteins in the blood indicate increased permeability of the muscle 
cell membrane (55). Mechanical damage also may promote an inflammatory response that 
involves an increase in fluid, plasma proteins, and inflammatory cytokines at the site of 
damage (95). 
1.1.1.2 Autogenic phase of lengthening contraction induced muscle damage 
The autogenic phase of muscle damage is caused by elevations in intracellular 
concentrations of Cai  (43). Whether the cause of the initial damage is metabolic or 
mechanical, there is diffusion of Cai ions into the sarcomeres (93). An early study 
demonstrated a degeneration of myofibrils when intracellular concentration of Cai was 
artificially increased through treatment with calcium ionophore (44). It was later established 
that, if the increase in intracellular Cai did not occur, muscle fibre damage was prevented (77). 
In a rodent model it was observed that exercise consisting of downhill walking resulted in 
increased Cai that accumulated within the mitochondria (43), and that this increase can alter 
the function of the sarcoplasmic reticulum as demonstrated in rodents (25).  
Failure of the sarcoplasmic reticulum to re-sequester Cai may lead to elevated intracellular 
Cai concentrations (8). It has been demonstrated that in single mouse muscle fibres, isolated 
muscles and rodents repeated stretches increase intracellular resting Cai (11, 74, 94). 
Increased concentration of intracellular Cai activates phospholipase A2, ubiquitin-proteosome 
and calpain-mediated proteases that primarily mediate degradation of the cell membrane and 
proteins, both structural and contractile (12, 147).  Phospholipase A2, activation promotes the 
production of arachidonic acid, which acts as a detergent to the cell membranes and results in 
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increased prostoglandins, leukotrienes and thromboxanes (8, 45). Treatment of muscle cells 
with cyclooxygenase inhibitors to reduce the formation of prostaglandins, leukotrienes and 
thromboxanes from arichidonic acid results in the prevention of leakage of muscle enzymes. 
Thus, it seems that enzyme leakage is not equivalent to physical damage to the plasma 
membrane (45, 76). Thus demonstrating that enzyme leakage is not caused by physical 
damage Acyl-CoA binding protein concentration can increase following sarcolemmal 
disruptions and can decrease the Cai concentration required for m-calpain activation from 300 
uM to around 10uM (99). Calpain Cai–dependant proteases degrade the z-disks, further 
disrupting the myofibrils (8). Additionally, stimulation of lysosomal proteases through 
calcium dependant mechanisms may play a role in the autogenic phase of muscle damage (8). 
Enhanced Cai-activated proteolytic activity results in further degradation of muscle proteins 
and lipid structures (56), which is evident in biopsy samples taken 2-5 days after exercise 
characterised high proportion of lengthening contractions that display more cellular disruption 
than those taken immediately after (49). Elevated resting intracellular Cai levels may lead to a 
greater number of cross-bridge formations, thus reducing the relaxation phase of contraction. 
This reduction in the relaxation phase of muscle contraction may be the cause of reduced 
range of motion of the associated joint and increased muscle stiffness following damaging 
exercise (89).  Furthermore, uncontrollable contraction of the muscle fibre may result in a 
depletion of local ATP stores, eliciting further structural damage due to both mechanical and 
metabolic stress (8, 26). However, it should be noted that the increases in Cai concentration 
have not been shown in humans and future studies are required to establish this. 
 
1.1.1.3 Phagocytic phase of lengthening contraction induced muscle damage 
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The phagocytic stage results in increased mobilisation of immune cells that are directed 
towards the injured tissue and is prevalent from 4-6 h to 2-4 d after the onset of damage (7). 
The tissue injury triggers the accumulation of bradykinin, histamine and prostaglandins that 
attract monocytes/macrophages and neutrophils. Neutrophils release chemo-attractants to 
promote the migration of other immune cells to the site of damage, however they are also a 
source of free radicals. The inflammatory cytokines, tumour necrosis factor-α (TNF- α), 
interleukin-1β (IL-1β) and interleukin-6 (IL-6)) are secreted by the immune cells (110). 
However, IL-6 also is released by exercising muscle (111). The infiltration of immune cells to 
the injured tissue is followed by a fluid influx and activation of type IV nerve endings, 
developing gradually over 3-4 days (115). 
Although resulting events from lengthening contractions are not completely understood, it 
is likely that there is mechanical stress that occurs immediately during the exercise resulting 
in metabolic homeostatic imbalance in the recovery period. There are many symptoms 
associated with unaccustomed lengthening contractions that include decreased muscle 
function (both reduced muscle force production and low frequency fatigue), increased muscle 
soreness, decreased range of motion and increased plasma concentrations of myofibre 
proteins. 
1.1.2 Methods to measure muscle damage 
It is difficult to directly measure muscle damage, however there are a wide variety of 
methods with which to assess it. Methods that have been used in previous studies include 
muscle function (usually measured by maximal voluntary contraction), 
immunohistochemistry (investigating membrane disruption), blood parameters (especially 
myofibre protein concentrations) and subjective measures of muscle soreness, such as a visual 
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analogue scale (139). The quantification of the observed magnitude and duration of damage 
can vary between the different methodologies (139).  
1.1.2.1 Muscle function 
A decrease in voluntary maximal force generation commonly occurs following 
unaccustomed exercise where there is a large number of lengthening contractions. It is 
generally the decrements in force production that cause reductions in athletic performance. 
Many studies have demonstrated significant reductions in power and strength following 
lengthening-based exercise protocols (29). Downhill running protocols produce damage and 
typically reduce maximal force production by 10-30% immediately following exercise (47, 
48). High-force, repeated lengthening contractions result in the greatest maximal force loss 
(35 – 50%) (105, 106, 117). Force loss resulting from intense exercise which has a high 
number lengthening contractions can last up to 2 wk (105).  
The force generation capacity of the muscle can be measured using maximal voluntary 
contraction (MVC). However, the subject’s motivation may have an influence on the outcome 
of an MVC measurement. Superimposition of an electrical stimulation to the muscle during 
the MVC will result in the production of maximal force by the muscle regardless of 
motivation. Thus, electrical stimulation during the MVC provides a indication of the impact 
of peripheral, rather than central, factors on muscle force production. However, even when 
this technique is adopted a reduction in force production following intense unaccustomed 
exercise still occurs (75). Therefore, it is likely that peripheral mechanisms (within the 
muscle) are the primary cause of the decline in muscle function following unaccustomed 
exercise involving a high frequency of lengthening contractions.  
The force frequency relationship of the muscle is another measure of muscle function. 
Comparison of force production at high and low frequencies indicates the force frequency 
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relationship of the muscle. A reduction in force at low frequencies indicates that there is an 
impairment of excitation-contraction coupling (141). This reduction is observed following 
intense exercise that has a high component of lengthening contractions. Muscle function is 
one of the most valid and reliable indirect measures of muscle damage in humans (139). 
Therefore, studies aiming to investigate injury from lengthening contractions should use 
muscle function as a marker of exercise-induced damage. We will implement two measures of 
muscle function, MVC with superimposed electrical twitch stimulation and low frequency 
fatigue in chapters 2 and 3. 
1.1.2.2 Muscle biopsies and myofibre proteins 
Many human studies have used both qualitative and quantitative histology analysis of 
muscle biopsies in an attempt to investigate disruption within the muscle tissue (34, 52-54, 
57-59, 65, 108, 123, 143). Within the biopsies the state of the fibres can be analysed to 
determine the amount of fibre degeneration and subsequently, the amount of regeneration. 
Furthermore, levels of enzyme activity and cellular membrane damage can be classified. It 
was recently demonstrated that the biopsy technique and / or the processing may lead to 
changes that can be mistakenly attributed to exercise-induced damage (96). Additionally the 
biopsy technique may lead to increases in myofibre proteins in the blood due to damage to 
muscle cell membranes, thus confounding other measurements (72). Furthermore, the muscle 
biopsy is small when compared to the whole muscle and quantification of damage of the 
whole muscle from a small sample is problematic, potentially under or over estimating 
damage (139). Often both the time-course and magnitude of disruption observed in muscle 
tissue biopsies correlate poorly with functional measurements of the muscle (139), so the 
practical meaning is difficult to interpret as people are often more concerned with functional 
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measures. However, the muscle biopsy technique is the only direct method in which to 
determine muscle structure disruption. 
Plasma concentrations or activity of myofibre proteins are often used as markers of muscle 
damage. These proteins include creatine kinase (CK), myoglobin and lactate dehydrogenase. 
CK is the most commonly measured of the myofibre proteins, although most of the proteins 
respond in a similar way. There is much debate surrounding myofibre proteins, in particular 
CK, as an indirect marker of muscle damage. It was suggested that CK appeared in the blood 
if there was muscle damage, however when measured there was no correlation between loss 
of muscle force production and the concentration of CK (27, 28, 105). Furthermore, the 
concentration of the myofibre proteins in the circulation is minimal in comparison to the total 
amount in the muscle and the permeability of the cellular membranes is mediated by 
arachidonic acid metabolites. Therefore it is not the physical breakdown of the membrane that 
is indicated by increased myofibre proteins in plasma, but if anything they may suggest 
increased membrane permeability (76). Nevertheless, changes in the plasma levels of these 
proteins are commonly used as an indicator of muscle damage.  
The greatest maximal force loss is generally seen immediately after the exercise bout, 
whereas CK levels have a biphasic response peaking at 24-48 h and then 96-120 h post 
exercise (139). Additionally, when repeated bouts of lengthening contractions are performed 
the maximum force decrement is less after each consecutive bout. However, the increase in 
CK concentrations remains large. Thus, there is no correlation between force decrement and 
CK concentrations following repeated eccentric exercise bouts. Furthermore, the response of 
CK to lengthening contractions is highly individualised (28). A difference in peak values for 
individuals has been shown to differ ~358% in response to the same relative intensity 
eccentric exercise bout (75). Therefore, comparisons between interventions are often 
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problematic, as it is difficult to decipher the effect of the intervention from that of individual 
responders and non-responders. Additionally, a one off measure of myofibre proteins in the 
blood does not only reflect their release into the blood stream but also their removal. CK is 
often measured to allow comparisons to previous studies, however it is not reflective of 
functional measures.  
1.1.2.3 Inflammation 
After muscle injury there is likely to be an inflammatory response. Magnetic resonance 
imaging can be used to determine swelling through measurements of the limb cross-sectional 
area. Alternatively, oedema within the limb can be calculated using T2 weighted contrast 
images or diffusion weighted images. Calculation of limb volume by measurement of the 
length and circumference of leg segments to calculate the volume of a cone (146) also may 
give an indication of swelling that has occurred to the limb. However, this measurement lacks 
resolution, thus small differences are unlikely to be detected. Due to the expense of the 
equipment required in chapters 2 and 3 we did not take any measures of limb swelling or 
oedema. 
Elevated levels of inflammatory cytokines, C-reactive protein and white blood cell counts 
in the blood are also consistent in an inflammatory response. Current evidence as to whether 
the response of cytokines in the blood is proportional to the damage is equivocal (97, 119). 
Therefore, studies should not only rely on the use of an inflammatory response to suggest 
damage. In chapters 2 and 3 we will measure interleukin 6 as an indicator of inflammatory 
cytokines in the plasma. However, this measurement may not be the most appropriate as IL-6 
is released from muscle in response to exercise and therefore is not be indicative of muscle 
damage. 
1.1.2.4 Muscle Soreness 
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Muscle soreness is associated with unaccustomed lengthening contractions and is the 
sensation of pain that usually peaks 2-3 d after the exercise bout. Soreness is frequently used 
as a measure of injury severity (139), and can be measured by application of pressure using a 
force transducer or by pain scales. The use of force transducers requires subjects to 
distinguish between pressure and pain, which is often difficult. Thus, there is a poor 
correlation between soreness values obtained from force transducers and soreness values for 
other measurement methods. Pain scales include rating of perceived soreness (RPS) and 
visual analogue scale (VAS). The RPS is a scale from 1 (not sore) to 10 (very very sore) in 
which subjects provide a value which best represents their perception of pain. The VAS can 
be either a 100 mm or 50 mm line anchored by ‘no soreness’ and ‘extremely sore’. Subjects 
mark the point along this line that best represents the soreness they feel. Scores are recorded 
by measuring the distance from the left hand anchor point (no soreness) to the marked point. 
It should be noted that whilst soreness scores are highly subjective, it has been shown that 
90% of pain ratings can be repeated within 9mm using a 10cm VAS (13). Thus, the VAS is 
considered effective in monitoring changes in perceived pain. In chapters 2 and 3 we will use 
a 10cm VAS to measure subjects pain. No numbers are recorded and therefore subjects are 
unlikely to be influenced by numbers they stated at the previous measuring point. 
 
1.1.3 Interventions to reduce muscle damage 
 Completing unaccustomed lengthening contractions can lead to a decrease in the 
ability to complete everyday activities. A premature return to strenuous activity, without 
recovery, may increase the risk of further injury (26). Therefore, it is important to restore 
maximal function as rapidly as possible. A range of treatments that may help alleviate 
symptoms associated with intense unaccustomed exercise have been suggested. These 
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treatments include the administration of nonsteroidal anti-inflammatory drugs, compression 
garments, cryotherapy,  and stretching (26). However, the efficacy of most treatment 
strategies across a range of populations (e.g. untrained, aging, athletes returning from injury) 
remains equivocal. Recently, studies have been performed in an attempt to investigate the 
potential impact of nutritional strategies in aiding the recovery from exercise-induced muscle 
damage. Specifically, the role of protein supplementation in attenuating muscle damage or 
speeding up the regeneration of new proteins to replace the damaged ones has been studied. 
However, these investigations provide equivocal results. 
1.1.3.1 Protein and amino acid sources 
Recent studies have focused on nutritional interventions during post exercise recovery 
in an attempt to alleviate muscle soreness and impairments in muscle function. An overview 
of studies that implemented a single bout of intense lengthening contraction-based resistance 
exercise with ingestion of protein and other amino acid sources is shown in Table 1.1. 
Although there are several studies investigating the efficacy of amino acids as a recovery tool, 
the results appear somewhat inconsistent. The effect of the ingestion of amino acid sources on 
muscle function, muscle soreness and blood parameters is equivocal. 
There are several reasons that may contribute to the differing results, including 
inconsistencies in exercise models, which prevent direct comparisons between studies. 
Exercise protocols previously implemented include arm curls (107), knee flexor/extensor 
exercise (24, 30, 31, 142), mixed lower limb exercise (33) and squats (81, 118). Furthermore, 
there are different types of supplements, including mixed amino acids (107, 125), 
carbohydrate with protein (30, 31, 142), milk (30, 31), single amino acids (81, 118), and 
different forms of whey protein, both isolate (24) and hydrolysate (24, 33). Additionally the 
controls vary from isoenergetic controls to flavoured water controls. The supplementation 
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pattern also has differed from a single bolus (31, 118) to 14 d of supplementation (33). 
Additionally, some studies measure muscle function with and without electrical stimulation. 
The type of subjects also varies between studies. Only two studies (30, 31) have investigated 
the effect of protein nutrition in trained subjects and only one study (118) has studied females. 
Lack of dietary control may help explain discrepancies between studies, as no study has 
strictly controlled diet of the subjects. Changes in energy and/or protein intake may have 
increased the variability in the response to the eccentric exercise that may have obscured any 
response to the interventions. Therefore it is difficult to determine whether discrepancies 
between studies are caused by the supplementation or variations in habitual energy and 
protein intake, thereby precluding the direct comparisons of inferences. 
1 
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1.1.4 Summary of muscle damage and nutrition 
Although exact mechanisms are not fully understood, unaccustomed lengthening 
contractions will induce muscle damage. Symptoms of muscle damage include increased 
soreness, loss of muscle force production, reduced LFF, inflammation, decreased range of 
motion and increased levels of myofibre proteins in the blood. These methods have their own 
limitations and the functional measures have been suggested as the most ecologically valid 
(139). Supplementation of protein and / or amino acids prior to and during recovery from 
eccentric exercise may speed up recovery. However dietary intake has not been sufficiently 
controlled in this area of research.  
Chapters 2 and 3 describe studies in which the effects of ingesting BCAA and whey 
protein on the detrimental effects associated with lengthening contractions were investigated. 
We measured muscle soreness using a VAS, maximal isometric strength with electrical 
stimulation, force frequency, plasma concentrations of CK and myoglobin and serum IL6 
concentration as an indirect marker of inflammation. Furthermore, we strictly controlled 
subjects’ diets. Resistance based exercise protocols were implemented as they produce the 
greatest decrements in force production and therefore maximise the chance of observing an 
effect of nutritional intervention. 
 
1.2 Muscle protein metabolism 
Muscle protein turnover refers to the constant and concurrent synthesis and degradation of 
muscle protein. Net muscle protein balance (NBAL) is the term used to describe the algebraic 
difference between muscle protein synthesis (MPS) and muscle protein breakdown (MPB) 
(136). A positive NBAL over a given time period is required to build muscle proteins. To 
achieve a positive NBAL the rate of MPS must exceed MPB. Conversely, if MPB exceeds 
MPS muscle protein loss occurs.  
Chapter 1: General Introduction 
 17 
 
1.2.1 Control of muscle protein synthesis 
 
1.2.1.1 Anabolic signalling 
Protein synthesis involves translation of a messenger RNA (mRNA) into a sequence of 
amino acids to form a polypeptide chain and then a functioning protein. Control of gene 
transcription and translation collectively regulate the synthesis rate of specific proteins. Gene 
transcription is the copying of DNA through complementary base pairing to form mRNA. 
This mRNA molecule is then transported out of the nucleus into the cytoplasm of the cell 
where translation of this mRNA molecule occurs.  
Translation is a process in which the mRNA is used as the template to form a polypeptide 
chain. Translation can be subdivided into three steps, initiation, elongation and termination. 
The purpose of initiation is for a translationally competent ribosome and the start codon 
(AUG) near the 5’ end of the mRNA to become joined together (109). Translation initiation 
can be categorised into three stages (80). Firstly, the specific inhibitor methionyl-tRNA has to 
bind to the small 40S ribosomal subunit forming the 43S preinitiation complex. The 43S 
preinitiation complex combines with the mRNA which is capped with eukaryotic initiation 
factor (eIF) 4F forming the 48S preinitiation complex. The combining of eIF4E, eIF4A and 
eIF4G into eIF4F is partially regulated by the reversible association of eIF4E with binding 
proteins, e.g. eIF4E binding protein (4E-BP1). The larger 60S ribosomal subunit then attaches 
to the 48S preinitiation complex creating the 80S active initiation complex.  The second stage 
of mRNA translation is elongation. Elongation involves reading the mRNA base sequence 
while building the polypeptide chain. The final stage of mRNA translation is termination. 
Termination occurs when the ribosome reaches the stop codon.  Usually, post-translational 
modifications occur to the polypeptide chain to form a functioning protein. 
Chapter 1: General Introduction 
 18 
Translation initiation and elongation are the main regulatory steps (138) and are controlled 
through signalling proteins. Mammalian target of rapamycin (mTOR) is controlled by the 
phosphorylation of a series of upstream proteins including phosphoinositol-dependent kinase 
1 (PDK1) and protein kinase B (Akt). During basal conditions mTOR and PDK1 are inactive, 
causing downstream molecules including p70-S6 protein kinase (S6K1) to be in their inactive 
form. Exercise and nutrition both have effect on the phosphorylation status of proteins 
associated with translation initiation. Similar to initiation, translation elongation is controlled 
by phosphorylation of proteins called eukaryotic elongation factors (eEF). eEF1A and eEF1B 
are active when they are phosphorylated and are involved in recruitment of the amino acyl-
tRNAs to the ribosome. The translocation of the ribosome along the mRNA is inhibited if 
eEF2 is phosphorylated (23). By measuring the phosphorylation status of signalling proteins, 
simultaneously with MPS, mechanisms of MPS in response to exercise and nutrition can be 
investigated. 
 
1.2.2 Measurement of muscle protein synthesis 
 
There are several methods that are used in order to measure muscle protein metabolism. 
Using a continuous infusion of an amino acid tracer is one of the more commonly applied 
methods to measure MPS. The tracer amino acid that is infused enriches the amino acid pools 
and proteins. The enrichments are then measured on a mass spectrometer. The rate at which 
amino acids are converted into proteins is calculated by the change in the enrichment of the 
tracer in the bound muscle over a given time period. Recently, the majority of studies 
implementing the precursor-product method have used labelled leucine or phenylalanine as 
the tracer. 
Chapter 1: General Introduction 
 19 
When using the continuous infusion precursor-product method measurement of MPS can 
be completed using the infusion of a tracer over several hours. Usually this method involves 
priming of the amino acid pool to achieve a steady state plateau of the infusion more quickly. 
Percutaneous muscle biopsies are obtained at two time points. The difference between the 
enrichment in the two biopsies over a period of time and the measurement of a precursor 
allows calculation of fractional synthetic rate (FSR). FSR is an expression of MPS and is 
calculated using the following formula: 
𝐹𝑆𝑅  % ⋅ ℎ!! = △ 𝐸!𝐸! ∙ 𝑡   ∙ 100 
where Em is the bound protein enrichment in the muscle and Ep is the precursor enrichment.  
 
The advantage of the precursor-product method is that it allows simultaneous measurement 
of whole body and muscle protein turnover. Furthermore, the synthesis rate of specific types 
of protein (e.g sarcoplasmic, myofibrillar) within the muscle can be calculated. The 
measurement of different protein fractions within the muscle is important as the turnover rates 
are different and the responses to exercise and nutrition differ (22, 102). In chapter 4 we will 
measure FSR using a primed continuous infusion of 13C6 phenylalanine. This method will 
allow us to measure myofibrillar protein synthesis. We will measure the tracer enrichment in 
the intracellular and extracellular fluid over the incorporation period to ensure that over the 
period of FSR measurement (i.e. the time between the biopsies) an isotopic steady state is 
achieved. Muscle intracellular free enrichments will be used as the precursor.  We will use 
phenylalanine as the tracer as it may be considered the best amino acid for measurement of 
FSR for several reasons (146). Phenylalanine has one of the smallest gradients between extra- 
and intracellular enrichments, thus minimizing possible errors in measurement of precursor 
enrichments. Moreover, phenylalanine has a relatively low endogenous turnover rate. Thus, 
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only a small amount of tracer is necessary. Leucine is often an alternative chosen to measure 
FSR, since whole body protein synthesis and breakdown may be measured simultaneously 
with leucine. However, phenylalanine is a better choice for our study, since the subjects will 
be ingesting leucine, thus making maintenance of an isotopic steady-state problematic.  
 
1.2.3 Muscle protein synthesis, exercise and nutrition 
Exercise of sufficient intensity can be a powerful stimulus to increase rates of MPS in the 
post-exercise period. However, following resistance exercise, despite increases in MPS, 
NBAL remains negative (14, 113, 114). In order to obtain a positive NBAL ingestion of an 
amino acid source is required (15, 116, 134). Therefore, a combination of exercise and 
provision of amino acids leads to the greatest increase in NBAL. Thus, in order to maximise 
muscle mass gain a combination of exercise and amino acid ingestion is required. 
1.2.3.1 Protein and amino acid ingestion 
Increased circulating amino acids are critical for increases in MPS. Both intravenous 
infusion (15) and ingestion (134) of crystalline amino acids created hyperaminoacidemia 
which resulted in positive NBAL and increased MPS following exercise. Further research 
demonstrated that NEAA were not required for increases in MPS either at rest (135) or 
following resistance exercise (21, 100, 134). Thus, the EAA are critical for increasing MPS. 
Furthermore, large increases in MPS were observed with only small amounts of EAA (21, 
100, 130). However, the practicality of ingesting pure amino acids may be questioned due to 
taste and expense. Therefore, studies have been performed in an effort to investigate the 
effects of ingesting proteins on muscle protein metabolism. Ingestion of intact proteins also 
increases MPS. Ingestion of whey, soy, casein and egg protein as well as milk and beef have 
all been shown to increase muscle anabolism (101, 126, 128, 129, 131, 132, 144). 
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1.2.3.2 Co-ingestion of carbohydrate and amino acids 
The ingestion of carbohydrate alone has been proposed to enhance MPS at rest (64). The 
responsible mechanism is likely through the enhanced delivery of nutrients to the muscle, 
secondary to the insulin induced vasodilation and capillary recruitment (32, 63). However, 
without provision of amino acids the stimulatory effect of carbohydrate is reduced (16). 
Previous studies have been designed to determine the effect of MPS following resistance 
exercise when carbohydrate is co-ingested with amino acids or protein. Ingestion of oral 
amino acids and carbohydrate following resistance exercise also has been shown to increase 
MPS during the post exercise period (100, 116). However, comparison of protein ingestion to 
the ingestion of protein plus high or low carbohydrate demonstrated no additional benefit on 
MPS of the carbohydrate (82). Furthermore, a bolus ingestion of carbohydrate and protein 
resulted in no further increases in MPS when compared to protein only (122). Glynn and 
colleagues (67) demonstrated no differences in MPS or MPB when a low or high 
carbohydrate dose was added to a high dose of EAA. Thus, in situations where there is ample 
protein provided carbohydrate does not play a synergistic or additive role on rates of MPS 
(67, 122).   
1.2.3.3 Effect of branched chain amino acids 
Following exercise, several studies have reported greater increases in MPS when higher 
plasma leucine concentrations are observed (101, 112, 129, 140). Different types of protein 
have different amino acid compositions. The ingestion of different types of protein results in 
different rates of MPS (112, 129, 144). For example whey protein ingestion following 
resistance exercise has been shown to increase MPS to a greater extent than casein or soy 
(112, 129). It has been suggested that it is the higher leucine content in whey protein that may 
be the cause of the higher MPS rates (112, 129). However, there appears to be a maximal rate 
of MPS even with increased leucine content. This notion was demonstrated by Moore and 
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colleagues (101) who showed that when egg protein dose was doubled from 20 to 40 g there 
were no further increases in MPS despite increases in leucine availability. Studies have 
investigated the effects of combining the ingestion of leucine with whey protein or EAA (38, 
61, 68, 84-86, 133). Leucine ingestion did increase MPS rates when compared to a non amino 
acid containing control (38, 61, 84). However, the muscle anabolic response was not greater 
when leucine was added to whey protein or EAA if compared to protein/EAA intake at rest 
(68) or following exercise (85, 86, 133). Therefore, it appears there is no further effect of 
leucine ingestion in situations where there is already ample amino acids ingested. Rodent 
studies have suggested that ingestion of BCAA, and in particular leucine, results in increased 
rates in MPS (2, 3). In humans there are limited studies that have focussed on the effects of 
BCAA ingestion alone on muscle protein metabolim. When measured by phenylalanine 
disposal and branched chain keto acid release there was no increase in protein synthesis, 
however proteolysis was reduced with BCAA infusion (92). Furthermore, Nair and colleagues 
(104) demonstrated that an infusion of leucine decreased protein degradation more than a 
saline infusion. Thus, there appears to be a role for BCAA in reducing MPB. The effect of 
BCAA ingestion alone, compared to a placebo, on MPS has never been investigated. Thus, in 
chapter 4 of this thesis the effect of BCAA ingestion following resistance exercise will be 
investigated. 
 
1.2.4 Anabolic signalling 
Following exercise, the response of MPS to exercise and nutrition is due to increased 
translation initiation (80). Rodent models have provided the majority of data examining the 
effect of nutrition and exercise on anabolic signalling (2, 3, 5, 17, 19, 20, 50, 88). Only 
recently have studies in humans measured the phosphorylation status of signalling proteins 
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simultaneously with MPS in an attempt to mechanistically determine the cause of increased 
MPS with exercise and nutrition. 
For many signalling proteins there is more than one site that can be phosphorylated. The 
phosphorylation status of S6K1 is commonly measured at two sites, Thr421/Ser424 and 
Thr389. It has been shown that muscular contractions have more influence on 
phosphorylation at Thr421/Ser424 (87, 145) and is not heavily influenced by circulating 
insulin or amino acid concentrations (83). Conversely phosphorylation of S6K1 at Thr389 is 
influenced by amino acid availability following exercise (38, 78, 83). Therefore, it is 
important to measure phosphorylation at the site that is appropriate for the assessment of the 
response of interest. For example, if a nutritional intervention is being investigated the 
phosphorylation status of S6K1 at Thr 389 should be measured. In chapter 4, we were 
interested in investigating the response to ingestion of BCAA following resistance exercise. 
Thus, we measured phosphorylation status of S6K1 at both Thr389 and Thr421/Ser424. 
Furthermore it appears there are many different signalling proteins which interact with 
each other. An insulin infusion alone resulted in increased phosphorylation of Akt, however 
leucine infusion did not (70), yet both resulted in increased phosphorylation of the 
downstream signalling protein S6K1. Thus, the data from that study (70) suggest that insulin 
and leucine result in phosphorylation of S6K1 via different signalling pathways. Thus in 
chapter 4 we measured an assortment of signalling proteins associated with mTOR including 
mTOR, Akt, Pras40, 4E-BP1, S6K1 and eEF2. 
1.2.4.1 Anabolic signalling: the effect of nutrition  
There are several studies that have measured the effect of nutritional intake only on 
intracellular signalling proteins (61, 66, 69-71, 73). Amino acids have been shown to activate 
mTOR with only basal insulin levels (71, 73, 138). However, many studies provide additional 
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carbohydrates that would enhance the insulin-stimulated phosphorylation of mTOR by the 
upstream kinase Akt (61, 69). The presence of insulin results in enhanced phosphorylation of 
signalling molecules both upstream and downstream of mTOR (40, 73).  However , in vitro 
studies (79, 148) have demonstrated that amino acids can activate mTOR independently of 
insulin, thus explaining how in the absence of hyperinsulinemia mTOR associated signalling 
proteins have enhanced phosphorylation when only amino acids are ingested (35, 70, 91). 
There appears to be some inconsistencies in the findings of nutrition on signalling proteins 
and this may be related to the inherent difficulties with the measurements or differences in 
biopsy timing or the composition of the nutrient intake. Several authors have demonstrated an 
increased S6K1 phosphorylation with amino acid feeding/infusion (61, 69-71, 73), conversely 
others have shown no differences in phosphorylation status (66). Furthermore, Fujita et al. 
(61) demonstrated that a leucine-enriched EAA and carbohydrate beverage increased 
phosphorylation status of S6K1, demonstrating the requirement of elevated insulin levels. 
Conversely, Greenhaff et al (69) reported that an intravenous infusion of amino acids without 
elevated insulin levels increased phosphorylation status of S6K1 above basal levels. Other 
signalling proteins (mTOR, Akt, 4EBP1) have also been shown to both increase and decrease 
in phosphorylation status in response to nutrient intake only (61, 66, 69-71, 73), for review 
see (41). Pras40 is another signalling protein that is influenced by insulin levels and 
influences the phosphorylation of mTOR through Akt (137). Thus, the measurement of the 
phosphorylation status of pras40 in chapter 4 will allow us to determine if changes in mTOR 
are via insulin mediated pathway and Akt. 
Of interest to the current thesis is the effect of ingesting only the BCAA on signalling 
proteins. It is proposed that leucine can regulate rodent MPS via enhancement of translation 
initiation (2-6, 18). Specifically leucine is involved in the phosphorylation of proteins which 
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control the 40S ribosomal subunit and mRNA binding. Furthermore, leucine has been shown 
to increase hyperphosphorylation of 4E-BP1 and increase phosphorylation of S6K1 (2, 5, 6), 
and will therefore both will be measured in chapter 4. Additionally, leucine exerts its’ effect 
directly on eIF4E and therefore, the eIF4F complex (2). 
The chosen methodological design implemented in chapter 4 did not allow us to measure 
the impact of nutrition alone on intracellular signalling proteins as we did not take biopsies 
from the rested leg. However, in the supplement we provided post exercise there were only 
the BCAA to allow for determination the signalling response without provision of additional 
insulin. 
1.2.4.2 Anabolic signalling: the effect of resistance exercise 
The mTOR signalling pathway has also been demonstrated to play a role in the regulation 
of MPS following resistance exercise. Drummond and colleagues (42) demonstrated that an 
infusion of a mTOR inhibitor resulted in a lack of increased post exercise MPS. During 
resistance exercise the increase in AMPK phosphorylation inhibits mTOR (37). However, in 
the recovery period from resistance exercise performed in a fasted state there are many studies 
that show an altered phosphorylation status of mTOR and downstream signalling proteins. 
(mTOR (39, 60), S6K1Thr421/Ser424 (46, 66, 87) and ribosomal protein S6 (rpS6) (66)). 
Phosphorylation of S6K1 is markedly increased following resistance exercise (36, 39, 46, 60, 
66, 87).  Several studies (9, 39, 42) have demonstrated that eEF2 is dephosphorylated 
following resistance exercise. These results suggest that resistance exercise also influences the 
elongation phase of translation.  
In chapter 4 although a placebo trial will be implemented, participants will have had a 
breakfast prior to the exercise and therefore we will be unable to determine the effect on 
signalling proteins of exercise alone. 
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1.2.4.3 Anabolic signalling: the effect of exercise and nutrition 
The combination of exercise and nutrition can influence MPS by regulating intracellular 
signalling proteins that control translation initiation. In general, there is a synergistic action of 
exercise and nutrition on phosphorylation status of mTOR associated signalling proteins (21, 
38, 62, 78, 86, 100, 116). Following resistance exercise protein and EAA ingestion have been 
demonstrated to alter phosphorylation status of S6K1 and 4E-BP1 (38, 62, 66, 78, 83). 
However, it should be noted that several studies have included carbohydrate in the feeding 
strategies (38, 66, 83). Thus, the altered phosphorylation status may be induced through 
insulin mediated pathways. Therefore, further studies are required, where only amino acids 
are provided, to fully elucidate the synergistic effect of resistance exercise and amino acid 
ingestion. Interestingly resistance exercise appears to maximally stimulate eEF2, with no 
additional effect observed when amino acids are ingested (38, 39, 66, 83). These results (38, 
39, 66, 83) suggest that there is no synergistic effect of resistance exercise and nutrition on the 
elongation phase of translation. There are very few studies that have investigated the 
combination of resistance exercise and BCAA ingestion on various mTOR related signalling 
proteins (78). In this study (78) it was demonstrated that repeated ingestion of branched chain 
amino acids led to an increased phosphorylation of S6K1 at both Thr 389 and Ser424/Thr 421 
sites. Additionally rpS6 was stimulated with BCAA ingestion. In chapter 4 we are going to 
measure Akt and mTOR associated signalling proteins following resistance exercise and 
BCAA ingestion. 
1.2.5 MPS and intracellular signalling 
To try and correlate differences in MPS and anabolic signalling, recent studies have 
combined the two measurements. Mixed muscle FSR was shown to increase by 41% 
alongside increases in phosphorylation of both mTOR and S6K1 2 h following exercise (39).  
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However, there is not always a correlation between MPS and signalling (69, 101, 122). 
Initially, increases in MPS following protein ingestion are associated with increases in 
phosphorylation of signalling proteins (10). However, these authors (10) demonstrated that 
when MPS returned to basal levels the phosphorylation status of signalling proteins remained 
elevated. The association of phosphorylation status and MPS when there is a combination of 
exercise and nutrition has not yet been fully investigated in humans. Thus, the relationship 
between signalling proteins and MPS still requires further investigation. mTOR signalling 
was enhanced and increased MPS rates were reported when a leucine, EAA and CHO drink 
was ingested and compared to a placebo (38). However, the measurement of MPS alongside 
signalling proteins, following the ingestion of BCAA following exercise has not been 
completed in humans. Thus, in chapter 4 we will simultaneously measure FSR and 
phosphorylation status of signalling proteins that are suggested to be influenced by both 
resistance exercise and BCAA ingestion. 
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2.1 Abstract 
 
Background: Inadequate recovery from unaccustomed exercise can limit exercise 
performance and also the ability to perform habitual activities. Repeated lengthening 
contractions or unaccustomed exercise leads to loss of muscle strength, an increase in muscle 
soreness and putative blood markers of muscle damage. Recently, nutritional interventions 
including branched-chain amino acids (BCAA) have been suggested to alleviate these 
symptoms. However, supplementation with BCAA has led to equivocal findings. Purpose: 
The purpose of this study was to examine the role of branched chain amino acid (BCAA) 
supplementation during recovery from intense lengthening contraction based exercise. 
Methods: Twenty-four non-weight trained males were assigned to one of two groups; one 
group (SUP) ingested BCAA beverages (n=12); a second group (PLA) ingested artificially 
flavoured water (n=12). Diet was controlled throughout the testing period to match habitual 
intake. The exercise protocol consisted of 12x10 lengthening contractions of unilateral knee 
extension at 120% concentric one repetition maximum. On the day of the exercise 
supplements were consumed 30 min before exercise, 1.5 h following exercise, between lunch 
and dinner and before bed. On the following two days four supplements were consumed 
between meals. Muscle soreness, muscle function and putative blood markers of muscle 
damage were assessed pre and post (1, 8, 24, 48, 72 h) exercise. Results: Maximal muscle 
force production decreased after the exercise bout (P<0.0001) but was unaffected by BCAA 
ingestion (-51± 3% with SUP versus -48 ± 7% with PLA). A decrease in flexed muscle 
soreness was observed in SUP compared to PLA at 48 h (21 ± 3 mm vs. 32 ± 3 mm; P=0.02) 
and 72 h (17 ± 3 mm vs. 27 ± 4 mm; P=0.038). Flexed muscle soreness, expressed as area 
under the curve, was lower in SUP than PLA (P=0.024). Conclusions: BCAA 
supplementation may attenuate muscle soreness, but does not ameliorate lengthening 
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contraction-induced decrements in muscle function or increases in reputed blood markers of 
muscle damage, when consumed pre and for 3 days after a bout of multiple lengthening 
contractions. 
 
Keywords: Nutrition, unaccustomed exercise, delayed onset muscle soreness, muscle 
function  
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2.2 Introduction 
 
Unaccustomed lengthening contractions result in decreased maximal force production (10, 
20), increased muscle soreness lasting several days (18) and increased concentrations of 
myofibre proteins (creatine kinase (CK) and myoglobin (Mb)) in the blood (6, 18). Thus, an 
impaired functional capacity of the muscle may prevent repeated exercise sessions which are 
required for adaptations to training i.e. an improved tolerance to the stress of resistance 
exercise or muscle hypertrophy. Nutritional strategies aimed at reducing the deleterious 
impact of lengthening contractions may be advantageous by allowing repeated exercise bouts 
of a superior quality to be performed.  
Recent studies have focused on nutritional interventions during exercise recovery in an 
attempt to alleviate muscle soreness and impairments in muscle function (18, 22, 24). Post 
exercise supplementation of protein and amino acids has been suggested to reduce the 
negative impact of lengthening contractions (6, 18, 23). However the results of these studies 
are equivocal. Muscle soreness and blood concentrations of myofibre proteins were decreased 
with supplementation of mixed free amino acids ingested in a fed state 30 min pre exercise, 
post exercise and during the 4-day recovery period (18). Supplementation of mixed amino 
acids twice a day for 10 days resulted in an attenuated loss of isometric contraction force 
following lengthening contractions (24). Similarly, during the first week of a 4-week 
intensified training resistance protocol impairments in maximum strength of squat and bench 
press were attenuated with 0.4g·kg-1·day-1 of amino acid supplementation (11).  
Conversely, mixed amino acid supplementation of shorter duration pre and post exercise in 
a fasted state had no impact on muscle soreness or blood myofibre proteins (18). Likewise, 
White et al. (31) demonstrated no differences in muscle function or soreness when comparing 
a protein/carbohydrate supplement to a placebo administered in a fasted state pre or post 
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lengthening contraction quadriceps exercise. Discrepancies between studies may be caused by 
the type or amount of amino acids in the supplements, whether the supplements are 
coingested with other nutrients, the duration of supplementary period, the degree of dietary 
control or the measurement tool used to assess the negative indices associated with intense 
lengthening contractions. Therefore, the effectiveness of amino acid or protein 
supplementation on attenuating muscle function loss, and elevation in muscle soreness and 
blood myofibre proteins appears somewhat equivocal at present. 
Positive effects of amino acid supplementation have been claimed to be related to the 
branched-chain amino acids (BCAA) (18). Recent interest has focused on the effectiveness of 
BCAA for reducing the negative symptoms associated with intense exercise (6, 8). To our 
knowledge only one preliminary study has investigated BCAA supplementation and recovery 
from intense lengthening contractions (23). These authors reported a reduction in muscle 
soreness following squat exercise with supplementation of only 5g BCAA in females (23). 
However, BCAA were ingested only once. At present no data examining the effect of 
ingestion of multiple supplements containing BCAA following multiple lengthening 
contractions in males. Therefore despite some evidence for the efficacy of BCAA in 
amelioration of adverse indices associated with intense exercise, the effectiveness of BCAA is 
not clearly established.  
Pilot data from our laboratory suggest high doses of whey protein ingestion may impact 
muscle soreness following resistant exercise. Mixed amino acids have also been shown to 
impact muscle soreness (18). BCAA have been suggested to be the active ingredient (18, 23). 
The aim of this study was to investigate the effectiveness of BCAA supplementation for the 
attenuation of the deleterious impact of an intense lengthening contractions in healthy males 
with no previous experience of regular resistance exercise. In accordance with Nosaka et al. 
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(18) showing an effect of amino acid supplementation, we provided supplements before, and 
in the four days following the exercise bout. In contrast to many previous studies, this study 
implemented strict dietary control, in order to ensure any differences that were observed could 
be attributed to the additional BCAA intake. 
 
2.3 Method  
 
2.3.1 Participants 
Twenty-four non-weight trained males were recruited for this study, which was approved 
by the University of Birmingham, School of Sport and Exercise Sciences Ethics 
Subcommittee. Subjects were made aware of procedures including the risks and benefits, gave 
written informed consent (Appendix A) and completed a general health questionnaire 
(Appendix B). Participants were able to withdraw from the study at any point without 
provision of reason. All participants refrained from physical activity and alcohol consumption 
for two days prior to testing and throughout the testing period. Participants were excluded if 
they had previous history of resistance training or had completed high intensity lengthening 
contraction based exercise within the last 6-9 wk (5).  
 
2.3.2 General Design 
Subjects were assigned to either a supplementary (SUP) or placebo (PLA) group and 
performed one single-blind experimental trial. Groups were matched for weight and one 
repetition maximum (1RM). Subject characteristics are shown in Table 2.1. An exercise 
protocol  consisting of lengthening contractions was implemented to allow comparison of 
putative blood markers of muscle damage, muscular dysfunction and muscle soreness 
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between SUP and PLA. Subjects consumed four supplements daily between meals. The 
composition of the supplement consumed by participants in SUP was 3.5 g leucine, 2.1 g 
isoleucine and 1.7g  valine mixed in 300ml artificially sweetened and flavoured water. The 
control supplement contained 300 mL of artificially sweetened and flavoured water. The 
artificial sweetener was free of amino acids. 
Table 2.1: Participant characteristics  
 Weight (kg) Height (m) 1 RM (kg) Leg Volume (ml) 
SUP 72.8 ± 10.4 1.80 ± 0.1 61.2 ± 9.3 5512 ± 1353 
PLA 74.9 ± 9.1 1.80 ± 0.1 62.3 ± 9.5 5725 ± 1094 
Values are expressed as means ± SD 
1RM = one repetition maximum 
Leg volume = volume of upper leg which was exercised calculated via anthrompetry (32). 
 
2.3.3 Pre testing 
Subjects visited the laboratory for preliminary measurements on two occasions. On the 
first, leg volume of the non-dominant leg was calculated (32). Determination of 1 RM of their 
non-dominant leg followed using a Cybex leg extension machine (Cybex international, USA). 
Subjects lifted an initial load which was then increased in increments of 2.5 kg. The subjects 
were instructed to lift the weight, hold it out-stretched for 2 s and then slowly lower it. 
Subjects rested for 3 min between lifts to minimise the impact of fatigue. Subjects were given 
a second attempt after the rest period if they failed with any given lift. This session also 
served as familiarization for the exercise protocol that followed. The familiarisation involved 
two lifts at 50% of their concentric 1 RM in which the weight was lifted by the researchers for 
the subject to lower. Subjects were strapped into the chair to ensure that the weight was lifted 
using only their leg. The subjects’ non-dominant leg was positioned at 90o to their torso with 
their knee flexed to approximately 110o. The lift started with the exercising leg positioned at 
approximately 15o of flexion. Two testers lifted the weight to its full extension; a ‘contract’ 
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command prepared the subject for the weight to be lowered. This command was followed by 
the command ‘release’ and the weight was released onto the subjects’ leg, and was then 
lowered by the subject, resisting the load. The weight was then lowered through 95o to bring 
the weight back to rest. Participants aimed to control the weight in the downward movement 
for 4 secs, if the movement was shorter in duration another repetition was completed. On the 
second visit to the laboratory, preliminary measurements were taken. These involved the 
measurements taken at each time-point, i.e. visual analogue scale (VAS), a blood draw and 
muscle function tests. 
 
2.3.4 Experimental Protocol 
On the day of the exercise protocol, subjects reported to the laboratory at ~06.00 h 
following an overnight fast (Figure 2.1). The subjects ingested their first supplement followed 
by a 30 min rest. The exercise protocol was then performed which lasted approximately 45 
minutes. Subsequently, subjects rested for an hour before the first measurements occurred. 
Pain was assessed using the VAS, followed by a blood draw. Finally, participants’ muscle 
function was assessed via maximal isometric strength (MIS) and low frequency fatigue (LFF) 
as described below. The order of these measurements was standardised for the 8, 24, 48, and 
72 h post exercise to eliminate measurement order from confounding results. Following 
completion of the 1 h testing, participants consumed another supplement before breakfast. A 
third supplement was ingested between lunch and dinner and the fourth at bedtime. On the 
three days following the exercise bout, all measurements were taken in the morning in the 
fasted state with the exception of the 8 h time-point. To maximise measurement reliability, all 
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measurements were carried out by the same investigator for each subject. 
 
Figure 2.1: Schematic protocol depicting the duration of the study.  
Criterion measures include; muscle soreness measures, blood draw, muscle function tests.   Exercise = 12 sets of 
10 repetitions of lengthening contractions of the quadriceps at 120% concentric 1RM. Supplements were 
consumed 4 times on the day of and two days following the exercise and were either BCAA or placebo. 
 
2.3.5 Diet and activity 
Prior to each trial, subjects were instructed to record a weighed three day diet record 
including at least one week day and one weekend day. An average energy intake from these 
three days was calculated and used to determine individuals’ energy requirements. All food 
was prepared and supplied to the subjects to ensure that any differences observed could be 
attributed to the supplements and diets were comparable between subjects. The diet was 
composed of 55% carbohydrates, 1.5 g protein / kg body mass (BM) with the remainder of the 
energy from fat. Prepared food was administered the day before, the day of, and two days 
following the exercise protocol. Food composition for the study is shown in Table 2.2. 
 
Table 2.2: Diet composition of food provided to the subjects  
 Energy Protein Carbohydrate Fat 
 kJ  g/kgBM/d  % En  g/kgBM/d  % En  g/kgBM/d  % En  
SUP 12305 ± 1677 1.5 ± <1 15 ± 3 5.7 ± 1.1 55 ± <1 1.4 ± 0.4 30 ± 3 
PLA 12026 ± 2074 1.5 ± <1 16 ± 3 5.3 ± 0.8 55 ± 4 1.3 ± 0.4 29 ± 6 
Values are expressed as means ± SD. 
% En: percentage of total energy intake. 
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2.3.6 Exercise protocol 
Subjects were seated as described previously and completed 12 sets of 10 lengthening at 
120% concentric 1RM, with 5 s rest between each repetition and 1 min rest at the end of each 
set. If the subject failed to control the weight for two consecutive repetitions, a rest period of 
30 s was given. During each contraction the subject was verbally encouraged to aid maximum 
effort. 
 
2.3.7 Muscle function 
Maximal isometric strength (MIS) was assessed using electrical stimulation with a 
Tornvall chair (7). Participants were seated so the knee was at 90o with a cord fastened round 
the ankle. This cord was attached to a strain gauge interfaced with a computer. Two arm 
straps held the subject in place in the chair. Damp electrodes (13 by 8 cm) were secured to the 
thigh over the proximal and distal ends of the quadriceps. Participants were electrically 
stimulated at their maximal electrical stimulation three times before being encouraged to push 
out with their leg against the cord as hard as possible. Three electrical stimulations were 
superimposed while contraction was occurring to ensure that the contraction was maximal. 
This procedure occurred three times at each time-point. The highest force obtained for each 
leg represented the subjects’ MIS. Another measurement of muscle function is LFF, i.e. a loss 
of force at low frequency stimulation common in damaged muscle (7, 10). Force frequency 
measurements occurred at one third of maximal electrical stimulation current. Electrical 
stimulation of the quadriceps at 20 and 100Hz for 2 s was performed in random order. The 
relationship between 20 and 100 Hz was used as an assessment of LFF. This procedure with 
electrical stimulation has been shown to not affect the response to initial exercise bout (14). 
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2.3.8 Muscle soreness 
Subjects rated general muscle soreness and soreness with the knee flexed and extended 
using a VAS. The VAS consisted of a 50mm line with anchor points of ‘no soreness’ on the 
left and ‘extremely sore’ on the right. Subjects marked a point along the line which 
represented the perceived soreness felt in the quadriceps muscle group. Pain was given a 
value by measuring the distance from the left anchor point. It has been shown that 90% of 
pain ratings can be repeated within 9mm using the VAS (2). 
 
2.3.9 Blood Analysis 
Plasma concentrations of CK and Mb were used to assess commonly measured putative 
markers of muscle damage. Serum was collected and analysed for interleukin-6 (IL-6) as an 
indirect marker of inflammation. Blood was drawn from the forearm vein of each subject at 
each testing point. Plasma samples were placed on ice, and serum samples were left at room 
temperature for 30 min to allow clotting. Samples were centrifuged at 3000 revolutions per 
min for 10 min at 4oC. Plasma and serum were extracted and stored in the freezer at -20oC 
until further analysis. Enzymatic analysis for plasma concentrations of CK (CK NAC CP, 
ABX diagnostics, UK) and Mb (myoglobin CP, ABX diagnostics, UK) were performed in 
duplicate at each time-point using a semi-automated analyser (COBAS MIRA S-plus, ABX, 
UK). Serum concentrations of IL-6 were analysed using commercially available sandwich 
enzyme-linked immunoabsorbent assay’s (ELISA’s) [High sensitivity Human IL6 assay, 
R&D systems, UK]. Plates were read in duplicate on a Labsystems Original Multiskan MS at 
selected wavelengths (490nm with correction at 630nm) Reported sensitivity of the ELISA is 
0.039 pg/mL. 
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2.3.10 Data presentation and statistical analysis. 
Data were analysed using statistical package for social sciences (SPSS) 15.0 for Windows 
(SPSS Inc., Chicago, IL). Differences across time for blood concentrations, force loss and 
VAS scores were analysed by a mixed design, two-way ANOVA with two between (SUP, 
PLA) and six or four (depending on variable analysed) within (time-points) subject variables. 
Significance was set at the 0.05 level of confidence. Where significance was found, least 
significant difference (LSD) post hoc tests were run to distinguish differences between 
supplementary groups. Missing data points were averaged from the other data sets for that 
time-point and group. This manipulation allowed a higher number of subjects to be included 
in the analysis to improve statistical power. VAS scores are shown as raw values and area 
under the curve (AUC) to give an indication of soreness over the 72 h experimental period. 
AUC baseline values were taken as a mean of preliminary values). Force frequency data were 
obtained by averaging values over a 1 s time period (0.8-1.8 s). Force frequency is shown as 
the percentage change from pre of the ratio between force value at 20Hz and 100Hz. Due to 
technical difficulties in this measure, data are shown for only n=10 in each group. MIS data 
were taken from the best value of three attempts and converted into Newtons from the volts 
value obtained. MIS values are shown as a percentage of the pre-exercise value to show the 
force that was lost, and using the pre value as a baseline. It was not possible to collect blood 
from one subject in PLA. Plasma CK, and Mb are depicted as percentage of each individual 
participants maximum. Serum IL-6 concentrations are shown as the mean concentrations. 
Data were also analysed using inferential statistics using 90% confidence limits to produce 
magnitude-based values about the probabilities of the outcome (1). For overall flexed 
soreness, an effect was assumed to be a change of 143mm*72h, and for extended soreness 
this value was 137mm*72h. These values were derived from the smallest standardized 
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(Cohen) difference in mean (0.2) multiplied by the standard deviation of PLA. The likelihood 
of the outcome being of beneficial or detrimental nature was also determined using a 
published spreadsheet (9). When the value is determined to be <1% detrimental or beneficial 
it is almost certainly not; 1-5% very unlikely, 5-25% unlikely, 25-75% possible, 75%-95% 
likely, 95-99% very likely and >99% almost certain. 
 
2.4 Results 
 
2.4.1 Muscle Function 
A decrease in MIS (Figure 2.2a) and in force frequency ratio (Figure 2.2b) was apparent in 
all subjects following exercise without difference between groups. The maximal percentage of 
force loss assessed using MIS was observed 48 h post exercise in both groups (SUP -51 ± 3 
%, PLA -48 ± 7 %). The lowest force frequency ratio was observed at 1 h post the exercise 
bout(SUP -42 ± 6 %, PLA -47 ± 5 %). 
 
Figure 2.2: Percentage change in leg muscle function pre and following 120 lengthening contractions. 
Depicted as a) electrically stimulated maximal isometric strength, b) 20:100Hz force frequency 
relationship.   
SUP = closed circles (Figure 2.2a, n=12, Figure 2.2b n=10) and PLA = open circles (Figure 2.2a, n=12, Figure 
2.2b n=10). Data expressed as means ± SE. * signifies significant difference from baseline in both groups. 
 
2.4.2 Muscle Soreness and Inflammatory Responses 
Chapter 2: BCAA ingestion and lengthening contractions 
 51 
The response of muscle soreness to the exercise bout is illustrated in Figure 2.3. The 
exercise protocol resulted in increased overall soreness in both groups. However no statistical 
differences were detected between SUP and PLA. Muscle soreness was also increased both 
with the knee flexed and extended. Soreness ratings tended to be lower at 8 h compared with 
1 h. Soreness then continued to significantly increase to peak soreness observed at 48 h. A 
main effect of SUP was observed (P<0.05). SUP resulted in a decrease in quadriceps muscle 
soreness with the knee flexed compared to PLA at both 48 h (21 ± 3 mm vs. 32 ± 3 mm; 
P=0.02) and 72 h (17 ± 3 mm vs. 27 ± 4 mm; P=0.038) post exercise (Figure 3a). There were 
no significant differences between SUP and PLA with the knee in an extended position. Over 
the total 72 h experimental period when data are expressed as AUC, muscle soreness with the 
knee flexed was 64% less for SUP compared to PLA (P=0.024) (Figure 2.3a). There were no 
statistical differences between SUP and PLA AUC with the knee in an extended position.  
Evaluation using inferential statistics showed SUP was 96.7% very likely beneficial, (700 
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± 490 mm, 90 % CL) for amelioration of muscle soreness with the knee flexed. Furthermore, 
the positive effects of BCAA in the extended position was 78.5 % likely beneficial effect (300 
± 420 mm 90 % CL) (Figure 2.3b). 
 
Figure 2.3: Muscle soreness pre and following 120 lengthening contractions measured using a 50mm 
visual analogue scale (VAS). a) knee in a flexed position, insert shows area under the curve b) knee in an 
extended position, insert shows area under the curve.  
SUP black bar/closed circles (n=12) and PLA white bar/open circles (n=12). * signifies significant difference 
from baseline. # significant difference of SUP from PLA. 
 
 
 
2.4.3 Blood parameters  
Serum IL-6 data are depicted in Figure 2.4. IL-6 concentrations significantly increased 
following the exercise protocol in both groups (P=0.02). At 24 h post exercise IL-6 
concentration had returned to normal. There were no differences in IL-6 concentrations 
observed between SUP and PLA. 
Figure 2.4: Serum interleukin-6 concentration measured pre-, 1, 8 and 24 h post 120 lengthening 
contractions.  
SUP closed circles (n=12) and PLA open circles (n=11). Data is means ± SE. * significant difference from 
baseline in both groups 
 
Plasma CK (P<0.001) and Mb (P<0.001) concentrations increased post exercise and 
remained elevated throughout the testing period (Figure 2.5a and 2.5b respectively). Peak CK 
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concentrations were observed between 8 and 24 h post exercise. Peak Mb concentrations were 
observed between 1 and 8 h post exercise. There were no significant differences observed 
between groups for plasma concentration of CK or Mb. In both blood metabolite 
concentrations a large inter-subject variability was observed.  
 
Figure 2.5: Myofibre concentrations in the plasma pre and following 120 lengthening contractions, 
expressed as raw values a) Creatine kinase concentration, b) Myoglobin concentration. 
SUP closed circles (n=12) and PLA open circles (n=11). Data is means ± SE. * significant difference from 
baseline 
 
2.5 Discussion 
 
In the present study we investigated the effects of BCAA supplementation on recovery 
from multiple lengthening contractions under conditions of strict dietary control. Our findings 
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are the first to suggest a beneficial role for BCAA supplementation following intense 
lengthening contraction based exercise in males. We observed a reduction of overall soreness 
in the quadriceps muscle with the knee in the flexed position. Additionally, we calculated that 
there was a likely beneficial effect of BCAA supplementation with the knee in an extended 
position. No differences in plasma myofibre concentrations, indirect measurement of 
inflammation or muscle function were detected between BCAA or placebo supplementary 
conditions when supplements were provided pre and for three days following multiple 
lengthening contractions. 
Amino acids intake may have an impact on muscle soreness. Supplementation with mixed 
amino acids (9 essential and 3 non essential) has previously been reported to decrease muscle 
soreness (18). In the present study, non trained subjects ingested only three amino acids 
(leucine, valine and isoleucine) at multiple time points post ex. Our results demonstrated that 
muscle soreness following the exercise bout was attenuated in the supplementation group, 
suggesting that BCAA are the active ingredient in protein for reducing muscle soreness. 
Interestingly, no effect of nutritional supplements containing BCAA in combination with 
other amino acids on muscle soreness have been observed in other studies (18, 31). Reasons 
for this discrepancy may be related to length of supplementary period and the total quantity of 
BCAA ingested. It would be of interest to determine if the beneficial effect on soreness we 
observed was replicated in a situation where only one of the BCAA were ingested. 
The amount of BCAA ingested may be a particularly important factor for amelioration of 
muscle soreness. Conflicting findings between present and previous studies may be explained 
by the length of supplementary period and consequently total intake of amino acids. Our 
subjects consumed supplements pre exercise and throughout the three day recovery period 
resulting in reductions in muscle soreness. Conversely, previous studies (18, 31) which 
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supplemented on only one or two occasions observed no differences in muscle soreness 
between experimental and control conditions. Interestingly, data in a review paper (23) 
demonstrated reduced muscle soreness following squat exercise with only a single bolus (5g) 
of BCAA. However this effect was observed in females but not males. The authors (23) 
attributed the difference to the fact that the females consumed a larger amount of BCAA 
relative to their muscle mass compared to the males, rather than a sex effect per se. Despite 
not having female subjects our findings may lend some support to this assertion. In our male 
subjects the total amount of BCAA intake per kg BM was even greater than in the females in 
the aforementioned study (23) resulting in decreased soreness. Thus, it seems feasible to 
suggest that a larger BCAA intake than in the previous study (23) may be necessary for any 
reductions in muscle soreness. 
Taken together the results of our study and those reported by Shimomura et al. (23) may 
suggest a threshold amount of BCAA relative to individuals muscle mass and to observe a 
decrease in muscle soreness this threshold must be reached. Therefore future studies should 
investigate BCAA intake relative to muscle mass 
The exact mechanism by which BCAA supplementation decreases muscle soreness cannot 
be deduced by our study design. Intense lengthening contractions are known to lead to an 
inflammatory response and an increased concentration of IL-6 (3). The exact cause of muscle 
pain is unknown, however it has been suggested that inflammation of the perimysium or 
epimysium may be causing the pain (12). The inflammatory response results in a sensitization 
of the muscle noiceptors leading to the common feeling of soreness (20). In the present study 
we measured circulating IL-6 concentrations. In accordance with previous studies which 
implemented carbohydrate feeding, no differences in IL-6 concentration were observed at any 
time-point with BCAA supplementation when compared to the placebo condition (13). Our 
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results suggest that BCAA supplementation did not alter this Il-6 response and therefore the 
BCAA are unlikely to mediate soreness via an IL-6 inflammatory pathway. Alternatively, 
soreness was reduced in both groups at the 8 h post exercise when subjects were in an early 
postprandial state. It may therefore be suggested that the extra energy intake from the 
supplements of ~117 kcal/day in SUP may have led to the decrease in soreness observed, 
however no mechanism is clearly indicated. 
Soreness may be modulated by feeding. Lower muscle soreness scores were recorded at 8 
h compared to 1 h post exercise in 19 of the 24 subjects. Measurements collected 8 h 
following the exercise were typically performed at ~ 15:00 h when participants were in a 
postprandial state, having eaten lunch within the previous 3 hours. We therefore propose that 
feeding may be responsible for this temporary reduction in perceived feelings of soreness. 
The present study is the first to record criterion measurements within 3 h of a meal. Recently, 
a novel experimental design was implemented (18) whereby lengthening contractions were 
performed in a fed and supplemented state. Analogous to our findings, mixed amino acid 
supplementation provided pre- and for four days post-exercise attenuated muscle soreness 
compared to a placebo group (18). Taken together, these data suggest amino acid 
supplementation combined with food intake may attenuate muscle soreness, possibly due to a 
larger availability of all amino acids. The association between soreness and feeding is an 
interesting concept; future studies should investigate whether there is a synergistic 
relationship. Other nutrients including carbohydrate and fat particularly in association with 
protein or amino acids should be investigated with regards to the impact on muscle soreness 
following intense lengthening contractions. Alternatively the delivery pattern of the amino 
acids may be modulated when combined with other nutrients, thus resulting in the reduced 
soreness observed in this study following a meal. 
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Intense bouts of lengthening contractions induce decrements in muscle force production in 
untrained individuals (18, 24, 31). In the present study, BCAA supplementation failed to 
ameliorate impairments in MIS. However previously Sugita et al. (24) exercised the elbow 
extensor muscles and provided a mixture of 12 amino acids for 10 days post exercise 
consisting of lengthening contractions.  These authors (24) reported attenuations in reductions 
of strength on days 2 and 3 post exercise. Some additional amino acids were ingested in the 
aforementioned study compared to the present study. It may be suggested that all essential 
amino acids, not only BCAA, may be necessary for successful amelioration of loss of muscle 
function. However, more recent studies (18, 31) that supplemented a mixture of amino acids 
or protein showed no effect on muscle function compared to placebo. Thus, future studies are 
required to fully elucidate how muscle function can be improved via nutritional interventions 
following intense lengthening contractions.  
The shift in force frequency relationship we observed mirrors those associated with LFF 
that is common with damaged muscle. Consistent with previous studies (14-16, 21) these data 
in the present study demonstrated a greater reduction in force at low frequencies compared to 
high frequencies following intense lengthening contractions (10). A comparison between the 
force production at the two frequencies may indicate if there has been greater reductions in 
force at lower frequencies. Reduction in force at low frequencies indicates that there is an 
impairment of excitation-contraction coupling (30). The present study was the first to 
investigate the effect of amino acid supplementation on LFF. However, BCAA ingestion did 
not impact upon the observed effect. Thus in the present study we observed no effect of 
BCAA on either measure of muscle function. Therefore our data demonstrating BCAA 
ingestion decreased soreness but had no effect on decrements in muscle function supports 
Chapter 2: BCAA ingestion and lengthening contractions 
 58 
previous research (29) which suggests that the relationship between muscle function and 
soreness is unclear.  
Muscle function following intense exercise may be, decreased due to increased muscle 
soreness. Twist and Eston (27) demonstrated that exercise-induced muscle damage increases 
perceived exertion and decreases performance during intense exercise. Whereas our study was 
not designed to investigate a relationship between muscle soreness and function, our result 
may offer some insights into this relationship. In the present study, soreness increased and 
muscle function decreased following the exercise bout as expected. However, whereas BCAA 
supplementation decreased muscle soreness, it has no impact on impaired muscle function. 
The most likely explanation for the apparent disconnect between the alleviation of muscle 
soreness with impaired muscle function is methodological. We used electrically-stimulated 
maximal voluntary contraction to test function of the muscle independent of motivation - or 
lack thereof - thus minimizing, if not eliminating, any reluctance to exert maximal force due 
to elevated muscle soreness. Alternatively, or additionally, the decrease in muscle soreness 
with BCAA supplementation may not have been sufficient to influence muscle function. 
More investigations specifically designed to investigate the relationship between soreness and 
function should be conducted. 
Previous authors attributed the attenuation of deleterious indices of lengthening 
contractions with amino acid supplementation to a modulated protein turnover (23). It is clear 
that essential amino acids stimulate muscle protein synthesis following exercise (25, 26), and 
resistance exercise with lengthening component stimulates muscle protein synthesis (19). 
Muscle protein turnover rates are low compared with other tissues (28) thus increases in the 
rate of muscle protein remodelling is likely to be insufficient to remodel enough proteins to 
explain these results in the short recovery period implemented in the present and previous 
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studies. No study to date has measured protein synthesis and breakdown in an experimental 
model of lengthening contraction based exercise and nutrition supplementation. It is difficult 
to comprehend that increased protein synthesis would account for improvements observed 
during only 2-3 days of recovery. Furthermore, it is difficult to imagine how increased net 
muscle protein balance could alleviate soreness even if turnover rates were very high. 
Intense lengthening contractions are known to elicit the release of CK and Mb into the 
blood. In the present study we observed increased plasma concentrations of both CK and Mb 
following exercise, however, BCAA ingestion did not alter the response. When comparing the 
magnitude of the CK response to endurance exercise in previous studies (6) with that 
observed in the present study, lengthening contractions if induces a higher CK response than 
the majority of endurance exercise. A reduction in CK activity with BCAA supplementation 
has previously been observed following lengthening contractions (6). CK and Mb levels are 
often erroneously considered as markers of muscle damage, in fact they are actually indicative 
of membrane disruption and ‘leaking’ of proteins from the muscle cell into the circulation. 
We measured myofibre concentrations to allow comparisons between other studies however, 
results showed a large variation in CK values between individuals. We demonstrate the peak 
response to be at 8 h post the exercise protocol which is earlier than previously demonstrated 
(29). However, within our results some subjects showed very high levels of CK compared to 
other individuals that showed very little increase in CK. Large inter-individual variability 
often observed in CK concentrations (4) may have accounted for the discrepancies in peak 
between this and previous studies (29). There were no correlations between the increase in 
CK and loss of muscle force, which is a more practical measure of the ability of the muscle to 
perform. These data add to existing data which suggest that myofibre protein responses are 
individualised and therefore may be considered weak predictors of muscle damage (29).  
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It is important to consider the practical implications of these results. Any attempt to 
extrapolate data generated in the present study to a trained population maybe non-sensical 
since untrained subjects were recruited. Athletes may respond differently due to the repeated 
bout effect (5, 14, 17) and the associated adaptations. However, these data may be applied to 
individuals starting an exercise regime or athletes returning to training following injury or off-
season may benefit from supplementing their diet with BCAA’s.  
In summary, supplementing a controlled diet with 29.2g/day of BCAA directly before and 
during short term recovery resulted in a decrease in soreness with the knee flexed and 
extended. However BCAA supplementation failed to ameliorate impairments in muscle 
function typically associated with intense lengthening contractions. No alterations in levels of 
myofibre proteins were observed in the plasma with BCAA supplementation. In conclusion 
BCAA is an effective aid in reducing soreness following intense lengthening contractions in 
healthy, untrained males. However, further studies are required to determine the mechanisms 
by which BCAA ingestion may lead to reductions in muscle soreness following multiple 
lengthening contractions. 
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Chapter 3: Whey protein ingestion attenuates muscle 
soreness and reduces decrements in muscle function 
in the first few hours following unaccustomed intense 
lengthening contractions 
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3.1 Abstract 
Purpose: Repeated lengthening muscle contractions or unfamiliar exercise leads to loss of 
muscle strength, an increase in muscle soreness and elevated concentrations in the blood of 
myofibre proteins. Recently, nutritional interventions, including protein, have been suggested 
to alleviate these symptoms. The aim of the present study was to measure the impact of whey 
protein supplementation on the negative indices associated with multiple lengthening 
contractions under controlled conditions. Method: The present study was a parallel, matched, 
single-blind design. Twenty four non-weight trained males ingested either whey protein 
beverages (WP) or carbohydrate beverages (CHO) for 3 d following an intense bout of 
lengthening contractions. Diet was controlled throughout the testing period to match habitual 
energy intake. The exercise consisted of 12x10 repetitions of unilateral lengthening 
contractions of the knee extensor muscles at 120 % concentric one repetition maximum. Four 
supplements were consumed each day over a 3 d recovery period. Muscle soreness, muscle 
function and putative blood markers of muscle damage were assessed pre and post (1, 8, 24, 
48, 72 h) exercise. Results: Maximal isometric strength decreased after the exercise bout 
(P<0.001). Additionally, there was a beneficial effect of ingesting WP on muscle function at 
all time-points post exercise. Protein ingestion resulted in reduced muscle soreness compared 
to carbohydrate ingestion at 8 h in general (WP: 10 ± 3 mm; CHO: 19 ± 3 mm) and in the 
flexed (WP: 12 ± 2 mm; CHO: 22 ± 4 mm) and extended (WP: 19 ± 3 mm; CHO: 32 ± 4 mm) 
positions. There were no differences in creatine kinase or interleukin-6 concentrations 
between conditions. Conclusion: These data suggest that protein supplementation may 
alleviate muscle soreness and reduce decrements in maximal force production. 
Keywords: Nutrition, unaccustomed exercise, delayed onset muscle soreness, muscle 
function  
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3.2 Introduction 
It is well established that unaccustomed lengthening contractions results in temporary 
decrements in maximal force production, low frequency fatigue, reduced range of motion, 
increased muscle soreness, increased inflammation and an increase in concentrations of 
myofibre proteins in the blood (6, 12, 18, 20). Recently, nutritional interventions, including 
protein and /or amino acids, aimed to reduce the negative indices associated with intense 
lengthening contractions have received considerable attention.  
Whereas the effectiveness of ingesting a source of amino acids to attenuate the decrease in 
muscle force production following lengthening contractions has been investigated, the effect 
of these amino acids remains equivocal. Whey protein hydrolysate was shown to accelerate 
the recovery of muscle force production following 100 lengthening contractions (4). 
Impairments in maximum strength of squat and bench press were attenuated with 0.4 g⋅kg⋅d-1 
of amino acid supplementation in the first week of a 4 wk overreaching resistance protocol 
(14). Similarly, supplementation with a selection of 12 amino acids resulted in a decrease in 
the loss of muscle force following exercise involving lengthening contractions (23). However, 
in another study (18), when these 12 amino acids were ingested pre and post lengthening 
contractions and when supplementation was continued over 4 d following the exercise bout 
no improvements were observed in maximal voluntary contraction compared to a placebo. We 
previously demonstrated that there were no differences in strength loss when branched chain 
amino acid (BCAA) beverages were compared with a placebo four times a day over a 3 d 
recovery period (11). Differing results between studies may be attributed to the differences 
between the methods used to measure muscle function, the type of supplement and length of 
supplementation. In the present study, we replicated the exact exercise protocol that we 
previously implemented (11) to allow for comparison between our present and previous 
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results. Additionally, we used electrical stimulation when measuring maximal muscle force 
productions to ensure that the values obtained were not influenced by voluntary effort or 
soreness of the subjects.  
In addition to differences in the exercise bout (intensity, muscles exercised), dietary control 
may help explain discrepancies between studies. Many studies did not control diet. Changes 
in energy and/or protein intake may have increased the variability in the response to the 
multiple lengthening contractions that may have obscured any response to the interventions. 
Therefore it is difficult to determine whether discrepancies between studies are caused by the 
supplementation or variations in habitual energy and protein intake. Thus, we provided all 
food for all subjects during the entire period of the study.  
Despite equivocal findings in relation to amino acid ingestion and the effect on muscle 
force production following lengthening contractions, evidence suggests that muscle soreness 
can be attenuated with amino acid supplementation. We recently demonstrated that under 
conditions of strict dietary control, supplementation of BCAA resulted in decreased muscle 
soreness (11). Other authors also have observed decreased soreness with supplementation of 
BCAA (22) and mixed amino acids that included BCAA (18). Thus, it is possible that the 
BCAA are the active ingredient in amino acid mixtures shown to attenuate soreness. On the 
other hand, other studies contradict these findings (18, 29). Different findings between studies 
may be due to the length of supplementation. The studies that observed no differences in 
muscle soreness with amino acid supplementation only provided supplements on the day of 
the exercise (18, 30), whereas those that reported decreased soreness provided the amino acid 
source for at least 3 d following the exercise (11, 18). Therefore in the present study we had a 
3 d supplementary period and matched the BCAA content to that of our previous study. 
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The aim of the current study was to determine if whey protein supplementation could 
attenuate the loss in maximal force production, rise in soreness and rise in inflammation when 
diet was controlled over a 3 d recovery period from intense exercise bout consisting of 
lengthening contractions. We hypothesised that similar to BCAA ingestion whey protein 
supplementation would ameliorate the increased muscle soreness observed following the 
exercise bout. 
 
3.3 Method  
 
3.3.1 Participants 
Non–resistance trained males (n=24) were recruited for this study, which was approved by 
the University of Birmingham, School of Sport and Exercise Sciences Ethics Subcommittee. 
Subjects were made aware of procedures including the risks and benefits, gave written 
informed consent (Appendix A) and completed a general health questionnaire (Appendix B). 
Participants were able to withdraw from the study at any point without provision of reason. 
All participants refrained from physical activity and alcohol consumption for 2 d prior to 
testing and throughout the testing period. Participants were excluded if they had a previous 
history of resistance training or had completed high intensity lengthening contractions within 
the last 6 wk. 
 
3.3.2 General Design 
Subject characteristics are shown in Table 3.1. Subjects were assigned to either a whey 
protein (WP) or iso-energetic carbohydrate (CHO) group and performed one single-blind 
experimental trial. Groups were matched for weight and one repetition maximum (1RM). An 
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intense exercise protocol consisting of lengthening contractions was implemented to allow 
comparison of putative blood markers of muscle damage, muscular dysfunction and muscle 
soreness between WP and CHO. Subjects consumed four supplements daily between meals. 
The composition of the supplement consumed by participants is detailed in Table 3.2. 
Table 3.1: Composition of supplements 
 Body mass (kg) Height (m) 1RM (kg) Leg volume (mL) 
WP 71.3 ± 4.3 182 ± 2.5 59.7 ± 9.2 5617 ± 1354 
CHO 72 ± 10.8 177 ± 4.3 62.5 ± 9.8 5795 ± 1289 
Values are expressed as means ± SD 
1RM = one repetition maximum 
Leg volume = volume of upper leg which was exercised calculated via anthrompetry (31). 
 
 
Table 3.2: Composition of supplements 
 Protein (g) Carbohydrate (g) Flavouring (g) Water (mL) 
WP 25.8 0 3.5 300 
CHO 0 25.8 3.5 400 
 
3.3.3 Preliminary testing 
Subjects visited the laboratory for preliminary measurements on two occasions. On the 
first, leg volume of the non-dominant leg was calculated (31). Determination of concentric 
1RM of their non-dominant leg followed using a leg extension machine (Cybex international, 
USA). Subjects lifted an initial load that was then increased in increments of 2.5 kg. The 
subjects were instructed to lift the weight, hold it out-stretched for 2 s and then slowly lower 
it. Subjects rested for 3 min between lifts to minimise the impact of fatigue. Subjects were 
given a second attempt after the rest period if they failed with any given lift. This laboratory 
visit also served as familiarisation for the lengthening contractions exercise protocol that 
followed. The familiarisation involved two lifts at 50 % of their concentric 1RM in which the 
weight was lifted by the researchers for the subject to lower. Subjects were secured into the 
chair to ensure that the load was lifted using only their leg. The subjects’ non-dominant upper 
leg was positioned at 90o to their torso with their knee flexed to ~110o. The lift started with 
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the exercising knee positioned at ~15o of flexion. Two testers lifted the weight to its full 
extension; a ‘contract’ command prepared the subject for the weight to be lowered. This 
command was followed by the command ‘release’ and the weight was released onto the 
subjects’ leg, and was then lowered by the subject while resisting the load. The weight was 
then lowered through 95o to bring the load back to its resting position. Subjects aimed to 
control the weight in the downward movement for 4 s. On the second visit to the laboratory, 
preliminary measurements were taken. These involved the measurements taken at each time-
point, i.e. visual analogue scale (VAS), a blood draw and a muscle function test. 
 
3.3.4 Diet and activity 
Prior to each trial, subjects were instructed to record a weighed 3 d diet record. An average 
energy intake from these 3 d was calculated and used to determine the energy requirements of 
each subject. All food was prepared and supplied to the subjects to ensure that i) any 
differences observed could be attributed to the supplements and ii) diets were comparable 
between subjects. The diet was composed of 55 % carbohydrates, 1.5 g protein/kg body mass 
(BM) with the remainder of the energy from fat, which was similar to their habitual diet. 
Prepared food was administered the day before, the day of, and 2 d following the exercise 
protocol.  
 
3.3.5 Experimental Protocol 
On the day of the exercise protocol, subjects reported to the laboratory at ~06:00 h 
following an overnight fast (Figure 3.1). The subjects ingested their first supplement followed 
by 30 min rest. The exercise protocol was then performed which lasted ~45 min. 
Subsequently, subjects rested for 60 min before the first measurements were carried out. Pain 
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was assessed using the VAS, followed by a blood draw from a forearm vein using a 
standardised venepuncture technique. Finally, muscle function was assessed via maximal 
isometric strength (MIS) as described below. The order of these measurements was 
standardised for the 8, 24, 48, and 72 h post exercise. Following completion of the 1 h testing 
period, participants consumed another supplement before breakfast. A third supplement was 
ingested between lunch and dinner and the fourth at bedtime. On the following 2 d 
supplements were consumed between meals. All measurements were taken in the morning in 
the fasted state with the exception of the 1 and 8 h time-point. To maximise measurement 
reliability, the same investigator carried out all measurements for each subject. 
 
Figure 3.1: Schematic protocol depicting the duration of the study.  
Criterion measures include; muscle soreness, blood draw, muscle function test.   Exercise = 12 sets of 10 
repetitions of lengthening contractions of the knee extensor muscles at 120% concentric 1RM. Supplements were 
consumed 4 times on the day of and two days following the exercise and contained either protein (WP) or 
carbohydrate (CHO). 
 
3.3.6 Lengthening contractions protocol 
Subjects were seated as previously described (11) and completed 12 sets of 10 lengthening 
contractions at 120 % concentric 1RM, with 5 s rest between each repetition and 1 min rest at 
the end of each set. If the subject failed to control the weight for two consecutive repetitions, a 
rest period of 30 s was enforced. During each lengthening contraction subjects were verbally 
encouraged to aid maximum effort. 
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3.3.7 Muscle function 
MIS was assessed using electrical stimulation with a Tornvall chair (7). Participants were 
seated so the knee was at 90o with a cord fastened round the ankle. This cord was attached to 
a strain gauge interfaced with a computer. Two arm straps held the subject in place in the 
chair. Damp electrodes (13 by 8 cm) were secured to the thigh over the proximal and distal 
ends of the quadriceps. On the first visit the subjects were familiarised to the electrical 
stimulation and current was increased until there was no further increases in force production. 
1.3 times greater than this current was then used for the superimposed electrical twitch 
simulations. Participants were electrically stimulated at their maximal electrical stimulation 
three times before being encouraged to push out with their leg against the cord with as much 
force as possible. Three electrical twitch stimulations were superimposed during muscle 
contraction to ensure that the contraction was maximal. This procedure occurred three times 
at each time-point with a rest of 3 min between attempts. The highest force obtained for each 
leg represented the subjects’ MIS. 
 
3.3.8 Muscle soreness 
Subjects rated muscle soreness generally and with the knee flexed and extended using a VAS. 
The VAS consisted of a 50 mm line with anchor points of ‘no soreness’ on the left and 
‘extremely sore’ on the right. Subjects marked a point along the line that represented the 
perceived soreness experienced in the quadriceps muscle group. Pain was given a value by 
measuring the distance from the left anchor point. It has been shown that 90% of pain ratings 
can be repeated within 9mm using the VAS (2). 
3.3.9 Blood Analysis  
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Plasma concentration of CK was measured as a putative marker of muscle damage. Serum 
was collected and analysed for interleukin-6 (IL-6) as an indirect marker of inflammation. 
Plasma samples were placed on ice, and serum samples were left at room temperature for 30 
min to allow clotting. Samples were centrifuged at 3000 revolutions per min for 10 min at 4 
oC. Thereafter, plasma and serum were extracted and stored in the freezer at -20 oC until 
further analysis. Enzymatic analysis for plasma concentrations of CK (CK NAC CP, ABX 
diagnostics, UK) was performed in duplicate at each time-point using a semi-automated 
analyser (COBAS MIRA S-plus, ABX, UK). Serum concentrations of IL-6 were analysed 
using a commercially available sandwich enzyme-linked immunoabsorbent assay (ELISA) 
(High sensitivity Human IL6 assay, R&D systems, UK). Plates were read in duplicate on a 
Labsystems Original Multiskan MS at selected wavelengths (490 nm with correction at 630 
nm). Reported sensitivity of the IL-6 ELISA is 0.039 pg/mL. 
 
3.3.10 Data presentation and statistical analysis. 
MIS data were taken from the best value of three attempts and converted into Newtons 
from the volts value obtained. MIS values are displayed as a percentage of the pre-exercise 
value to show the force that was lost. The MIS value recorded at pre was used as the baseline.  
VAS scores are shown over the course of the study period. Moreover, we calculated area 
under the curve (AUC) to give an indication of soreness over the total 72 h experimental 
period. Since any differences between groups seemed to be due primarily to changes in the 
first 24 h, we also chose to calculate AUC of soreness for only the first 24 h period. AUC 
baseline values were calculated from the mean of preliminary values. Plasma CK 
concentrations and serum IL-6 concentrations are shown as the mean of the raw 
concentrations.  
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Data were analysed using statistical package for social sciences (SPSS) 17.0 for Mac 
(SPSS Inc., Chicago, IL). Differences across time for blood concentrations, force loss and 
VAS scores were analysed by a mixed design, two-way ANOVA with two between (WP, 
CHO) and six or four (depending on variable analysed) within (time-points) subject variables. 
AUC values were compared using an unpaired students t-test. Significance was set at the 0.05 
level of confidence. Where significance was found, least significant difference (LSD) post 
hoc tests were run to distinguish differences between supplementary groups. Missing data 
points were averaged from the other data sets for that time-point and group. This 
manipulation allowed a higher number of subjects to be included in the analysis to improve 
statistical power. 
Data also were analysed using inferential statistics with 90 % confidence limits to produce 
magnitude-based values about the probabilities of the outcome (1). The likelihood of the 
outcome being of beneficial or detrimental nature also was determined using a published 
spreadsheet (9). The P value (Probability value), , degrees of freedom, percentage level for 
confidence, threshold values (meaning of an effect) and an effect statistic were entered. The 
value of an effect statistic was calculated as the difference between the mean of each group. 
For overall general soreness, an effect was assumed to be a change of 137 mm * 72 h and 50 
mm * 24 h for flexed soreness, this value was 146 mm * 72 h, and 54 mm * 24 h and for 
extended soreness this value was 137 mm * 72 h and 50 mm * 24 h. These values were 
derived from the smallest standardized (Cohen) difference in mean (0.2) multiplied by the 
standard deviation of CHO (control condition). For MIS each time-point post exercise was 
compared back to the corresponding pre value and inferences were made on the comparison 
of these differences between groups. Inferential values were derived from the log of raw data 
and calculated using a published spreadsheet (8). When the value is determined to be <1% 
Chapter 3: Whey protein ingestion and lengthening contractions 
 74 
detrimental or beneficial it is almost certainly not; 1-5 % very unlikely, 5-25 % unlikely, 25-
75 % possible, 75%-95 % likely, 95-99 % very likely and >99 % almost certainly. 
3.4 Results 
 
3.4.1 Muscle Function 
A decrease in MIS (Figure 3.2) was apparent in all subjects following exercise. The mean 
maximal percentage of force loss assessed using MIS was observed 24 h post exercise in WP 
(-59 ± 7 %) and 48 h post exercise in CHO (-57 ± 7 %). Using inferential statistics protein 
ingestion was likely beneficial at 1 (95 % beneficial) and 8 h (80% beneficial) post exercise.  
 
Figure 3.2: Percentage change in leg muscle function pre and following  120 lengthening contractions.  
Depicted as electrically stimulated maximal isometric strength. Data expressed as means ± SE. * significant 
difference from baseline in both groups. Supplements were consumed 12 times over the testing period and 
contained either protein (WP) or carbohydrate (CHO). Inferential statistics show a beneficial effect of WP 
compared to CHO at 1 and 8 h. 
 
3.4.2 Muscle Soreness 
The temporal pattern of muscle soreness to multiple lengthening contractions over the 72 h 
period was similar in all three positions. Soreness with the knee in a flexed position is shown 
in Figure 3.3A. The exercise protocol resulted in increased overall soreness in both groups. 
Soreness ratings were lower at 8 h compared with 1 h (p=0.03) in both groups. In all positions 
of the leg, peak soreness was observed at 1 h in CHO and at 48 h in WP. Additionally 
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soreness was significantly lower in an extended position at 1 h post exercise in WP compared 
to CHO. 
Over the total 72 h experimental period when data are expressed as AUC, muscle 
soreness with the knee flexed was 30 % less for WP compared to CHO (Figure 3.3B). 
However, t-test indicated no statistical difference between groups. Inferential statistics 
showed WP was likely beneficial for amelioration of overall muscle soreness in all knee 
positions (Table 3.3).  
 
Figure 3.3: Muscle soreness pre and following 120 lengthening contractions measured using a 50 mm 
visual analogue scale (VAS). a) knee in a flexed position over 72 h, b) area under the curve of flexed 
muscle soreness over the entire 72 h period.   
Data are expressed as means ± SE. * significant difference from baseline in both groups.  Supplements were 
consumed 12 times over the testing period and contained either protein (WP) or carbohydrate (CHO). Inferential 
statistics show a beneficial effect of WP compared to CHO. 
 
Table 3.3: Muscle soreness inferentials for 72h  period 
Knee 
position 
P value Value ± 90% 
confidence limits 
Outcome 
General 0.1369 290 ± 320 79% (likely) beneficial 
Flexed 0.1 340 ± 340 83% (likely) beneficial 
Extended 0.1848 330 ± 420 79% (likely) beneficial 
 
Over the first 24 h period only, total soreness in all three positions expressed as AUC 
was significantly lower in WP than CHO (Figure 3.4). Evaluation using inferential statistics 
showed WP was very likely beneficial for amelioration of overall muscle soreness in the first 
24 h following the exercise bout with the knee in all positions (Table 3.4). 
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Figure 3.4: Muscle soreness with knee flexed for the first 24 h as area under the curve (AUC) following  
120 lengthening contractions measured using a 50 mm visual analogue scale (VAS).  
Data are expressed as means ± SE. # significant difference between groups. Supplements were consumed 12 
times over the testing period and contained either protein (WP) or carbohydrate (CHO). Inferential statistics 
show a beneficial effect of WP compared to CHO. 
 
Table 3.4: Muscle soreness inferentials for the 24h period 
Knee 
position 
P value Value ± 90% 
confidence limits 
Outcome 
General 0.0153 190±130 97% (very likely) beneficial 
Flexed 0.0077 220 ±130 98% (very likely) beneficial 
Extended 0.004 250±130 99% (almost certainly) beneficial 
 
3.4.3 Blood parameters  
Serum IL-6 data are depicted in Figure 3.5. IL-6 concentrations significantly increased 
following the exercise protocol in both groups. IL-6 concentration had returned to baseline by 
24 h post exercise. No differences in IL-6 concentrations were observed between WP and 
CHO. 
 
Figure 3.5: Serum interleukin-6 concentration measured pre-, 1, 8 and 24 h post- exercise.  
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Data are expressed as means ± SE. * significant difference from baseline in both groups. Supplements were 
consumed 12 times over the testing period and contained either protein (WP) or carbohydrate (CHO). 
 
Plasma CK concentration increased post exercise and remained elevated throughout the 
recovery period (Figure 3.6). Peak CK concentrations were observed at 8 h post exercise in 
CHO and 72 h post exercise in WP. No significant differences were observed between groups 
for plasma concentration of CK. A large inter-subject variability was observed in CK 
responses, with peak values ranging 100-fold (184 -18150 U/L).  
 
Figure 3.6: Plasma creatine kinase concentrations in the plasma pre and following 120 lengthening 
contractions.  
Data are expressed as means ± SE. * significant difference from baseline in both groups. Supplements were 
consumed 12 times over the testing period and contained either protein (WP) or carbohydrate (CHO). 
 
3.5 Discussion 
The present study investigated whether the ingestion of whey protein, providing 
BCAA in amounts previously demonstrated (11) to reduce muscle soreness before and 
following intense lengthening contractions, improved indices of recovery when compared to 
an isoenergetic beverage. We observed a reduction in overall soreness in the quadriceps 
muscle over the first few hours following the exercise bout with whey protein 
supplementation. Furthermore, we determined that there was a likely beneficial effect of whey 
protein supplementation on muscle soreness over the entire 72 h period. Additionally, there 
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was a likely beneficial effect of whey protein on muscle function at 1 and 8 h post exercise. 
However, no differences in plasma concentration of a putative marker of muscle damage 
(CK), or an indirect measurement of inflammation (IL-6) were detected between whey protein 
and an isoenergetic placebo when supplements were provided pre and for 3 d following an 
intense bout of lengthening contractions. Thus, it seems whey protein ingestion following 
multiple intense lengthening contractions impacts muscle soreness and muscle function within 
the first few hours of recovery. 
The impact of whey protein ingestion on muscle soreness seems to be due primarily to 
the amino acid content of the protein rather than other factors such as energy content. In the 
present study we aimed to compare the effects of a complete amino acid source with that of an 
isoenergetic non amino acid containing beverage. We recently demonstrated that 
supplementing a controlled diet with BCAA’s only resulted in reduced overall soreness at 48 
h and 72 h post exercise (11). Additionally, a preliminary study (22) reported reduced muscle 
soreness following squat exercise. Supplementation with mixed amino acids (9 essential and 3 
non essential), including BCAA, has previously been reported to reduce muscle soreness (18). 
In the present study untrained subjects ingested all amino acids, including the same amount of 
BCAA as in our previous study (11) and we observed a reduction in muscle soreness. 
Therefore, taken together, these data suggest that the beneficial effect of the whey protein on 
muscle soreness may be related to the BCAA content. Moreover, the addition of other amino 
acids as in the present and a previous study (18) do not hinder this amelioration of muscle 
soreness. It would be interesting to compare the effects of a whey protein containing beverage 
with a beverage containing only the NEAA to see if the NEAA are required. 
Negligible effects of supplementation on muscle soreness also have been previously 
reported. Interestingly, mixed amino acids (18) and protein plus carbohydrate (30) 
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supplements have been shown to have no influence on muscle soreness. The reason for the 
discrepancy between the present and previous studies is unknown. Careful comparison 
between study designs reveals a range of exercise intensities, limbs used, supplements 
provided, timing of supplementation and, for many, a lack of dietary control. Another factor 
that seems to be important is the length of supplementation period. When protein was 
provided pre or post exercise only no effect was observed on muscle soreness (30). We 
provided multiple supplements over a 3 d recovery period and observed improvements in 
soreness in the present and previous study The importance of an extended supplementary 
period is further supported by Nosaka et al (18), who demonstrated that with the same 
supplement content and exercise implemented (intensity and limb used), there was only a 
reduction in soreness when supplements were provided over 3 d of recovery. Thus, even 
within the same research group and when the same supplement is used the length of 
supplementation appears to influence the results. However, there are some studies that 
observed decreased soreness with only one dose of amino acid ingestion (21, 22). Therefore, a 
systematic investigation of the various aspects of study design and effect on muscle soreness 
should occur before solid recommendations can be made. 
Whereas in the present study we observed a reduction in soreness with whey protein 
supplementation, the mechanism cannot be deduced using our data. It previously has been 
suggested that the feeling of pain is caused by inflammation of the perimysium or epimysium 
(15). A sensitization of the muscle nociceptors caused by the inflammatory response results in 
the common feeling of soreness (20). Intense lengthening contractions are known to lead to an 
inflammatory response which may be represented by an increased the circulating 
concentrations of the inflammatory cytokine IL-6 (3). However, as in previous studies (11, 
16) in the present study we observed no differences between supplementation groups in the 
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response of IL-6 when whey protein or carbohydrate was ingested.  Thus, our data do not 
support the suggestion that reduced muscle soreness with whey protein supplementation was 
modulated via an inflammatory response. However, the measurement of IL-6 is only looking 
at one inflammatory pathway, and does not solely represent muscle inflammation. Future 
studies are required to fully elucidate the mechanisms that result in the decreased soreness 
with amino acid supplementation, these studies may include other measures of inflammation 
including magnetic resonance imaging to measure oedema or swelling in the exercised limb. 
It is possible that muscle soreness may contribute to the reduction of muscle function. 
It is known that an increase in perceived pain decreases performance (26). It also has been 
suggested that the cause of force loss with lengthening contractions, as in the present study, is 
partially driven by central mechanisms, but mainly caused by peripheral mechanisms (10). In 
the current study we employed electrical stimulation to obtain MIS. The use of electrical 
stimulation allowed us to measure muscle function independently of motivation, therefore 
likely diminishing resistance to maximally exert force due to pain. Hence, we attempted to 
reduce central mechanisms that might confound results. Thus, we compared force generated 
with whey protein supplementation and the control condition observing only peripheral 
mechanisms. Even when using electrical stimulation, we still observed decrements in muscle 
force in both conditions, suggesting that the force loss was caused by a peripheral mechanism. 
Furthermore, there was a reduced loss of muscle function and amelioration in soreness with 
whey protein ingestion compared with carbohydrate. Therefore, protein may impact 
peripheral mechanisms that cause decreased muscle force following intense lengthening 
contactions. However, from the data collected in the current study we are unable to deduce 
mechanisms to explain how ingestion of whey protein impacts peripheral mechanisms related 
to force production. 
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The timing of supplementation or the form of ingested protein may be important for 
attenuating force loss from lengthening exercise. In the present study we provided whey 
protein isolate and observed an amelioration of the decrement in muscle function over the first 
few hours following resistance exercise. Our results contradict those of Buckley et al. (4) who 
demonstrated that whey protein hydrolysate, but not whey protein isolate, resulted in an 
attenuation of the decrement in muscle function following lengthening contractions. We 
provided supplements pre and post exercise, however Buckley et al. (4) provided the first 
supplement after the post exercise measurements. Thus, it is possible that the provision of 
whey protein isolate post the exercise bout only, does not effectively attenuate decrements in 
muscle function. Thus, we suggest whey protein isolate may be effective for attenuating loss 
of maximal force production after intense lengthening contractions if provided both pre and 
post exercise. However, more studies should be completed in order to fully understand if there 
are any differences in muscle function recovery between ingesting whey protein hydrolysate 
and isolate following lengthening contractions.  
From our data the cause of improved muscle function over the first few hours of 
recovery with ingestion of whey protein compared to carbohydrate is unclear. Previous 
authors attributed the attenuation of deleterious indices of multiple lengthening contractions 
with amino acid supplementation to a modulated protein metabolism (22). However, it is 
highly unlikely that any differences in muscle function in the first few hours can be attributed 
to increased protein synthesis. It is known that protein ingestion can stimulate muscle protein 
synthesis (13, 24, 25). However, the turnover rate of muscle protein synthesis is low (28), thus 
any increases in muscle protein synthesis is unlikely to remodel proteins sufficiently in the 
short time frame in which we observed changes in muscle function. Therefore, future studies 
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should look to examine the mechanisms by which decrements in muscle function are reduced 
with whey protein ingestion. 
Plasma CK concentration increases following lengthening contractions. Myofibre 
proteins are often used as markers of muscle damage. However, elevated concentrations of 
myofibre proteins in the blood are more likely indicative of loss of membrane integrity due to 
disruption of structural elements within the muscle (29). This notion is further supported by 
evidence that the release of myofibre proteins into the blood can be prevented in rats if 
vitamin E is provided (27) due to the interaction with the membrane phospholipids (19). In 
our hands, whey protein had no impact on reducing CK concentrations following intense 
lengthening contractions. Previously, blood concentrations of myofibre proteins were 
decreased with supplementation of mixed free amino acids ingested in a fed state 30 min pre 
exercise, post exercise and during a 4 d recovery period (18). However, various other amino 
acid supplementation strategies have failed to reduce the increase in myofibre proteins 
observed following intense lengthening contractions (11, 18). Reasons for these discrepant 
findings are likely due to substantial variability observed between individual CK responses to 
eccentric exercise. We observed a wide variation in responses - up to 100-fold. Our 
observation of high inter-subject differences is consistent with existing literature (29) and 
further highlighted the inherent problems associated with using CK as a predictor of muscle 
damage. We used parallel group design, thus different subjects in each group may have 
contributed to the lack of observed differences between experimental groups.  
 The practical implications of the results from this study are not entirely clear. These 
results suggest that ingestion of whey protein, as a supplement, may be beneficial for reducing 
soreness and decrements in muscle function primarily during the first few hours following 
exercise when compared to ingestion of carbohydrate. However, if compared to previously 
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published data (11) ingestion of whey protein reduces the decrement in muscle function more 
than water in the later stages of recovery. We chose to measure the responses in untrained 
individuals to maximise our ability to detect any differences. The responses may very well be 
different in those individuals more accustomed to this type of exercise (5, 17). Thus, the 
impact of whey protein on soreness and muscle function may be limited to untrained 
individuals and may not apply to those who train regularly. It is possible that individuals 
beginning a training regime or athletes returning to training following an injury may show 
similar responses and therefore benefit from whey protein ingestion. However, as discussed 
previously (11), the physiological relevance of this finding may be questioned. Particularly 
for previously sedentary individuals, it is possible that reduced soreness immediately 
following exercise from ingesting whey protein may help to increase exercise adherence. 
Thus, our results may be used to suggest ingestion of whey protein as an aid to help increase 
exercise participation. 
In summary, supplementing a controlled diet with 103 g/d of whey protein directly 
before and during short-term recovery from multiple lengthening contractions resulted in a 
decrease in muscle soreness and attenuated decrements in muscle function over the first few 
hours of recovery. In conclusion whey protein is an effective aid in reducing soreness and 
reducing muscle function decrements following intense lengthening contractions in healthy, 
untrained males. 
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4.1 Abstract 
Purpose: Ingestion of essential amino acids are known to stimulate muscle protein 
synthesis. It is often speculated that BCAA ingestion is important for increases in muscle 
protein synthesis (MPS). However, no study has investigated the effect of ingesting only 
BCAA following resistance exercise on MPS. Therefore, the purpose of this study was to 
investigate the effect of ingesting BCAA on MPS, in association with leg resistance exercise. 
Method: Using a counterbalanced, crossover, double blind design, ten weight-trained males 
completed two trials consuming either a BCAA containing beverage or a placebo (PLA) post 
resistance exercise. Diet was controlled for two days prior to each infusion trial to match 
habitual caloric intake and dietary composition. The exercise consisted of 4 x 10 repetitions at 
70 % one repetition maximum on a leg press machine and 75 % on a leg extension machine. 
Trials were performed following intake of a high protein (30 % energy) breakfast. Protein 
synthesis was measured over the 4 h recovery period by a primed, constant infusion of L-[ring 
13C6]phenylalanine. Muscle biopsies were obtained from the vastus lateralis immediately, 1 h 
and 4 h post resistance exercise and blood samples were collected throughout the trial. 
Western blotting was used to determine the phosphorylation status of P70 ribosomal protein 
S6 kinase (p70S6K) (Thr389 and Ser424/Thr421), ribosomal protein S6 (Ser235/236), 4E-
binding protein (Thr37), protein kinase B (Thr308) and pras 40 (Thr246). Results: Plasma 
BCAA concentrations were significantly higher in BCAA than PLA following drink 
ingestion. Peak leucine (652 ± 43 nmol/L), isoleucine (355 ± 24 nmol/L) and valine (785 ± 47 
nmol/L) were observed at 0.5 h post drink ingestion in BCAA and remained elevated for 3 h. 
FSR was 22 % higher in BCAA (0.11 ± 0.009%/h) than PLA  (0.09 ± 0.006 %/h) over the 4 h 
recovery period. There were no differences between conditions in any of the signaling 
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proteins measured. Conclusion: Our results indicate that MPS can be further increased from 
resistance exercise by ingesting BCAA. 
Keywords: Nutrition, intracellular signaling, protein, fractional synthetic rate 
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4.2 Introduction 
Branched chain amino acids have long been associated with muscle anabolism. In vitro 
studies demonstrated that there was no increase in protein synthesis when the branched chain 
amino acids were omitted from amino acid perfusions (24). Studies in resting humans 
demonstrated a role of ingesting a specific branched chain amino acid, leucine, in muscle 
anabolism (29). In a rats leucine supplementation increased muscle protein synthesis 
following a running exercise above exercise alone (1, 2). However, the exercise resulted in 
decreased muscle protein synthesis, leaving the rats in a catabolic state. Therefore, leucine 
ingestion returned muscle protein synthesis levels to pre exercise levels, rather than increasing 
muscle protein synthesis above basal levels. The restoration of muscle protein synthesis rates 
was accompanied by increases in phosphorylation status of intracellular signalling proteins 
(1). In humans a decrease muscle protein synthesis has never been shown in the recovery 
period following exercise.. Additionally, the effect of leucine or branched chain amino acids 
on muscle protein synthesis in humans following exercise is unknown. 
The exact mechanisms by which leucine or the branched chain amino acids exert their 
anabolic action remain unclear. However, increases in intracellular signalling lead to 
increased protein synthesis through elevated translation initiation and elongation in vitro and 
in animals. Leucine increases translation initiation and elongation signalling in resting 
humans (12). A recent study by Karlsson et al. (17) demonstrated that repeated ingestion of 
branched chain amino acids led to increase in phosphorylation of p70 protein kinase S6 
(S6K1) at both Thr 389 and Ser424/Thr 421 sites following resistance exercise. Additionally, 
ribosomal protein S6 (rpS6) was stimulated with branched chain amino acid ingestion. 
Whereas no measure of synthesis was made by Karlsson et al. (17), it was assumed that this 
difference in phosphorylation of S6K1 and rpS6 would result in differences in muscle protein 
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synthesis (6, 15). However, it is important to note that assessment of anabolic signalling only 
provides a snapshot of potential translational control. It is for these reasons that direct 
measurements of muscle protein synthesis through stable isotopic tracer methodology are now 
widely employed in parallel with measures of signalling protein phosphorylation status. 
It is well known that the ingestion of essential amino acids and protein following resistance 
exercise results in increases in muscle protein synthesis (8, 36, 42, 44). Whereas, the ingestion 
of leucine alone following resistance exercise has never been studied, the co-ingestion of 
leucine with both essential amino acids (EAA) (10) and whey protein (20-22, 41) has been 
investigated. However, the effect on muscle protein synthesis of ingesting additional leucine 
remains equivocal (10, 20-22, 41). The ingestion of leucine with protein or EAA resulted in 
greater post exercise muscle protein synthesis rates compared to exercise alone (10, 20). 
However, in these studies (10, 20) the effect of leucine is difficult to distinguish from that of 
the protein or EAA that was co-ingested, as there was no comparison to the ingestion of only 
EAA or protein following exercise. However, other studies that have investigated muscle 
protein synthesis rates following exercise after ingestion of leucine plus protein have made 
comparisons to protein ingestion alone and exercise (21, 22).  This comparison allows the 
effect of leucine to be determined. These studies (21, 22) suggest that there was no additional 
effect on muscle protein synthesis with the ingestion of leucine plus protein compared to 
protein only. Similarly there is no further increase in muscle anabolism following exercise 
when leucine is added to whey protein compared to whey protein alone (41).  
To date no studies have investigated the effect of branched chain amino acids ingestion 
alone following resistance exercise. There is reason to believe the ingestion of leucine alone 
results in a fall in the concentrations of other branched chain amino acids (41) likely due to 
increased branched chain alpha keto acid dehydrogenase activity (5). Therefore, to prevent a 
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fall in the concentrations of isoleucine and valine it would be logical to provide all branched 
chain amino acids within a supplement investigating the muscle protein synthesis. Hence, we 
provided all branched chain amino acids following a bout of resistance exercise. Branched 
chain amino acids have been shown to increase phosphorylation status of signalling proteins, 
however not alongside a measure of muscle protein synthesis. Thus, we measured signalling 
proteins simultaneously with muscle protein synthesis in trained human males. Resistance 
trained athletes typically train 2 -3 h after a meal. Hence, for practical reasons the study 
design was such that we provided a high protein breakfast so that the exercise would be 
completed following food intake. We hypothesised that the ingestion of branched chain amino 
acids following resistance exercise would not only increase the phosphorylation status of 
mammalian target of rapamycin (mTOR) related signalling proteins, but also increase muscle 
protein synthesis. 
 
4.3 Method 
4.3.1 Subjects 
Eleven healthy males who completed regular resistance training of the lower body (≥ 2/ wk 
≥ 6 mo) were recruited for the present study. Due to subject illness only 10 subjects 
completed both trials. Therefore data are shown only for 10 subjects. The mean (± SD) age 
was 20.1 (± 1.3) y, body mass 83.3 (± 11.7) kg, and percentage lean mass 86.1 (± 4.1) %. The 
design, purpose and potential risks associated with the study were explained to the subjects 
before obtaining written, informed consent (Appendix C). Exclusion criteria were metabolic 
disorders (as determined by health questionnaire (Appendix B)), food intolerances/allergies, 
allergies to local anaesthetic, current participation in other clinical trials, blood donations 
within three months of the initial screening visit and the prescription of medication or 
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nutritional/dietary supplements suggested to affect protein metabolism. All trials were 
conducted in the laboratories of the School of Sport and Exercise Sciences, University of 
Birmingham, following ethical approval by National Research Ethics Service ethics board 
(Warwickshire). 
 
4.3.2 Study Design 
Subjects reported to the laboratory on five separate occasions including two experimental 
trials separated by ≥ 3 wk. During the initial visit body composition was assessed using Dual-
Energy X-ray Absorptiometry (DEXA) and one repetition maximum (1RM) was predicted for 
each leg individually. Approximately 1 wk later, subjects returned to the laboratory to 
confirm their 1RM on one leg. Two days later subjects performed their first blinded trial in 
which they consumed either a branched-chain amino acid containing beverage (BCAA) or a 
placebo (PLA) (Lucozade, GlaxoSmithKline, Brentford, UK) (Table 4.1). Subjects performed 
a unilateral bout of resistance exercise prior to consuming the test drink in each trial. 
Myofibrillar protein synthesis was determined by measurement of the incorporation of L- 
[ring-13C6] phenylalanine into muscle protein during a primed continuous infusion and urea 
production was measured through infusion of 15N2 urea. The complete testing procedure was 
repeated on the contralateral leg ~3 wk after the first trial. Trial and exercised leg order were 
counter-balanced and randomised. 
Table 4.1: Contents of test drinks 
 BCAA PLA 
Calories (Kcal) 39 13 
Leucine (g) 2.6 0 
Isoleucine (g) 1.4 0 
Valine (g) 1.6 0 
Carbohydrate (g) 3.1 4.6 
Fat (g) 0.01 0.02 
Sodium (g) 0.2 0.2 
Drinks were consumed after the unilateral bout of resistance exercise and were either a branched chain amino 
acid containing beverage (BCAA) or a placebo (PLA). 
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4.3.3 Preliminary testing 
4.3.3.1 Exercise sessions  
At least 6 d before and < 2 wk prior to the first infusion trial session, 1RM was predicted 
for both legs of each subject using a previously published method (45). Subjects warmed up 
each leg, before completing the maximum number of repetitions at 80 % of the subjects own 
prediction of 1RM. This load was then inserted into equation 1 to estimate 1RM (30).  
       (1) 
Three days prior to the infusion trial days subjects returned to the laboratory to confirm 
their 1RM (23) on the leg that was to be exercised in the forthcoming trial. Briefly, the load 
was set to 90 % of the estimated 1RM from equation 1. Subjects completed the maximum 
number of repetitions possible. The load was then increased by 5-10% until only one 
repetition could be completed. A rest period of 3 min was given between each load.  
4.3.3.2 Diet and physical activity:  
Participants completed a weighed 3 d diet record prior to commencement of the testing 
period to provide an estimate of habitual macronutrient composition as analysed by a 
commercially available software program (Wisp V3.0, Tinuviel software). Food was provided 
for 2 d prior to the infusion trial and matched that of their individual habitual intake. Subjects 
were instructed to consume all food provided and asked to refrain from eating after 22:00 on 
the evening prior to the infusion trial.  During this 2 d period subjects were asked to refrain 
from exercise and alcohol.  
4.3.3.3 Body Composition:  
Body composition was assessed using DEXA (Hologic Discovery W, Hologic Inc., 
Bedford, Massachusetts, USA). 
 
1RM = load1.0278! 0.0278( )•reps
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4.3.4 Experimental Protocol 
A schematic of the trial protocol is displayed in Figure 4.1. Subjects reported to the 
laboratory at ~ 06:15 following an overnight fast where standard measures of height and 
weight were taken. A cannula was inserted into a forearm vein of one arm, and a resting blood 
sample was obtained. Thereafter, subjects were fed breakfast (30 kJ/kg body mass (BM)) with 
30% total energy provided by protein. After breakfast a primed, continuous infusion of 15N2 
Urea (Cambridge Isotope Laboratories Inc, Andover, Massachusetts, USA) was started and 
continued throughout the protocol. The priming dose relative to body mass was 88 
µmol/kgBM and the infusion rate 0.227 µmol⋅min -1⋅kgBM-1. Subjects rested for ~ 75 min 
before a primed (2 µmol/kgBM) constant infusion (0.050 µmol⋅min-1⋅kgBM-1) of L-ring 13C6 
phenylalanine (Cambridge Isotope Laboratories Inc, Andover, Massachusetts, USA) was 
started.  
105 min later, subjects performed a single bout of unilateral leg resistance exercise which 
lasted ~25 min. Subjects completed a warm up on the leg press machine (Cybex VR3, Cybex 
International, Medway, Massachusetts, USA), which consisted of 12 repetitions at 40 % 
1RM, 10 repetitions at 50 % 1RM, eight repetitions at 60 % 1RM and two repetitions at 70 % 
1RM. The warm up was followed by a 2 min rest period. The resistance exercise protocol 
consisted of four sets of 10 repetitions at 70 % and 75 % 1RM on the leg press and leg 
extension machine (Cybex VR3, Cybex International, Medway, Massachusetts, USA), 
respectively. Subjects rested for 2 min between each set and were free to consume water ad 
libitum. A floor standing fan was used to cool subjects and verbal encouragement was 
provided to all subjects throughout the protocol. If a subject could not complete a full set, the 
load was lowered by 4.5 kg. On completion of each set subjects were asked to rate their 
perceived exertion using a Borg scale (BORG). Immediately after exercise (t=0 min), an 
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arterialised blood sample and a muscle biopsy were collected followed by the ingestion of the 
test drink. Arterialised blood samples were also collected at t = -240, -145, -85, -25, 0, 15, 30, 
45, 60, 75, 90, 120, 150, 180, 240 min. Two further muscle biopsies were collected at t = 60 
and 240 min.  
 
 
 
 
 
 
 
 
 
Figure 4.1: Schematic diagram of the infusion protocol.  
Drink ingestion was of either a placebo or branched chain amino acid containing beverage. 
 
4.3.5 Muscle biopsy collection and analysis 
Muscle biopsies were obtained from the vastus lateralis of the exercised leg under local 
anaesthesia (1 % lidocaine) using 5 mm Bergstrom needles with suction. Different incisions 
(~1 cm apart) were used for each biopsy in an attempt to minimize the impact of local 
inflammation from the previous biopsy sample. Biopsy samples were immediately rinsed, 
blotted of excess blood, removed of visible fat and connective tissue and divided into aliquots, 
before being frozen in liquid nitrogen, and stored at -80°C until later analysis. Muscle 
samples were analysed for enrichment of L- [ring-13C6] phenylalanine in the intracellular pool 
and bound myofibrillar protein fractions, Furthermore, muscle was analysed to measure 
phosphorylation of mTOR related signalling proteins. 
4.3.5.1 Myofibrillar protein enrichment 
Muscle tissue was analysed for enrichment of L- [ring-13C6] phenylalanine in the 
myofibrillar protein fraction. Myofibrillar proteins were isolated from ~30 mg tissue as 
previously described (32). Briefly muscle was snipped in ice-cold homogenizing buffer (50 
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mM Tris-HCL, 1 mM EDTA, 1 mM EGTA, 10 mM β-glycerophospahte and 50 mM sodium 
fluoride). The homogenate was shaken for 10 min prior to being centrifuged at 1000 g for 10 
min at 4 oC. The pellet was then re-suspended in homogenisation buffer, before being and 
shaken and centrifuged as above. The myofibrillar fraction was separated from any collagen 
by dissolving the pellet in 0.3 M NaCl and heating for 30 min at 37 oC. The proteins were 
then precipitated by combining the supernatant with 1M PCA before being centrifuged for 20 
min at 3500 rpm at 4 oC. The pellet was then washed with 70% ethanol. The remaining 
myofibrillar pellet was hydrolysed overnight at 110 ºC in 0.1 M HCl/Dowex 50W-X8 100-
200 (Bio-Rad laboratories INC, USA) and the liberated amino acids purified on cation-
exchange columns (Bio-Rad laboratories INC, USA). Amino acids were then converted to 
their N-acetyl-n-propyl ester derivative and the phenylalanine labelling determined by gas-
chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS, Delta-plus XL, 
Thermofinnigan, Hemel Hempstead, UK). Ions 44/45 were monitored for unlabelled and 
labelled CO2 respectively. 
4.3.5.2 Intracellular protein enrichment 
Intracellular amino acids were liberated from ~20 mg of muscle. The frozen tissue was 
powdered under liquid nitrogen using a mortar and pestle and 500 µL of 1 M perchloric acid 
(PCA) was added. The mixture was centrifuged at 10,000 g for 10 min. The supernatant was 
then neutralised with 2 M potassium hydroxide and 0.2 M PCA and combined with 20 µL of 
urease for removal of urea. The free amino acids from the intracellular pool were purified on 
cation-exchange columns as described above. Intracellular amino acids were converted to 
their MTBSTFA derivative and 13C6 phenylalanine enrichment determined by monitoring at 
ions 234/240 using gas chromatography mass spectrometry (GCMS) (model 5973; Hewlett 
Packard, Palo Alto, CA). 
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4.3.5.3 Western blots:  
20-30mg of muscle tissue was powdered on dry ice. Approximately 20mg of powdered 
muscle was homengised in lysis buffer (50mM Tris pH 7.5; 250mM Sucrose; 1mM EDTA; 
1mM EGTA; 1% Triton X-100; 1mM NaVO4; 50mM NaF; 0.50% PIC), using a hand-held 
homogenizer (PRO200, UK). Samples were shaken for 1h at 4oC, before being centrifuged for 
5min at 6000g. The supernatant was then used for determination of protein. A DC protein 
assay (Bio Rad, Hertfordshire, UK) was used for protein concentration. Equal amounts of 
protein were then boiled in Laemmli sample buffer (250mM Tris-HCl, pH 6.8; 2% SDS; 10% 
glycerol; 0.01% bromophenol blue; 5% β-mercaptoethanol) and separated on SDS 
polyacrylamide gels (10-15%) for ~1h at 58mA. Proteins were then transferred to a protran 
nitrocellulose membrane (Whatman, Dassel, Germany) at 100V for 1h. Membranes were 
blocked using milk solution and then incubated overnight at 4oC with the appropriate primary 
antibody. The primary antibodies used were, rpS6Ser235/236 (Cell signalling 2217), S6K1Thr389 
(Cell signalling 9234), S6K1 Ser421/Thr424 (Cell signalling 9204), AktThr308 (Cell signalling 
4056), Aktser473 (Cell signaling 3787), 4E-BP1Thr37 (Santa Cruz SC6025), eEF2Thr56 (Cell 
signalling 2332), and PRAS40Thr246 (Cell Signalling 2610). The following morning the 
membrane was rinsed in wash buffer (TBS with 0.1% Tween-20). The membrane was then 
incubated for 1h at room temperature with the appropriate secondary antibody, either 
horseradish (HRP)-linked anti-mouse IgG (New England Biolabs, 7072; 1:1,000) or anti-
rabbit IgG (New England Biolabs, 7074; 1:1,000) diluted in wash buffer. The membrane was 
then cleared of the antibody using wash buffer. Antibody binding was detected using 
enhanced chemiluminescence (Millipore, Billerica, MA). Imaging and band quantification 
were carried out using a Chemi Genius Bioimaging Gel Doc System (Syngene, Cambridge, 
UK). 
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4.3.6 Blood collection and analysis 
Blood was collected in LH- and EDTA-containing and serum separator tubes and 
centrifuged at 3500 rpm for 15 min at 4 °C. Blood was collected into the different tubes for 
different analysis, some of which my be affected by the anticoagulants within the tubes. 
Aliquots of plasma and serum were then frozen at -80 °C until later analysis. Plasma glucose 
and urea concentrations were analysed using an instrumentation laboratory automated blood 
metabolite analyser (Instrumentation Laboratory 650, Instrumentation Laboratory, Cheshire, 
UK). Serum insulin was measured using a commercially available ELISA (DRG Diagnostics, 
USA) following manufacturers instructions.  
4.3.6.1 Amino acid concentrations and enrichments 
13C6 enrichments of tyrosine and phenylalanine were determined by GCMS (model 5973; 
Hewlett Packard, Palo Alto, CA) by monitoring ions 234/240. Once thawed, plasma samples 
were mixed with diluted acetic acid and purified using a cation-exchange column (Bio-Rad 
laboratories INC, USA). The amino acids were then converted to their N-tert-butyldimethyl-
silyl-N-methyltrifluoracetamide derivative. Simultaneously, concentrations of phenylalanine, 
leucine, threonine, isoleucine and valine were determined using an internal standard method 
(42, 44). Briefly, plasma samples were weighed to obtain ~ 300 µL, 30 µL of an internal 
standard containing U-13C9-15N phenylalanine (ions 336/346), U-13C6 leucine and isoleucine, 
(ions 302/308), U-13C4-15N threonine (ions 405/409) and U-13C5 valine (ions 288/293) was 
then added and weighed. From knowing the weight of both sample and internal standard we 
could obtain a tracer to tracee ratio. As we also knew the concentration of the amino acids in 
the internal standard we converted the tracer to tracee ratio into a concentration of each amino 
acid in the plasma.  
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4.3.6.2 Urea enrichments 
15N2 enrichments of urea were determined from plasma collected in LH vacutainers. Once 
thawed, plasma samples centrifuged at 3500 rpm for 10 min at 4 oC. 10 µL of plasma was 
then mixed with 120 µL ethanol. Samples were then left in the fridge for 30 min prior to 
centrifugation at 13000 rpm for 20 min at 4 oC. The supernatant was then removed and dried 
under nitrogen. TBDMS and acetonitrile were then added to the dried sample prior to heating 
at 90 oC for 90 min. Samples were then run on GCMS (model 5973; Hewlett Packard, Palo 
Alto, CA) and ions 231 and 233 were monitored. 
 
4.3.7 Calculations 
4.3.7.1 Fractional synthetic rate 
The fractional synthetic rate (FSR) of myofibrillar proteins was calculated using the 
standard precursor-product method:  
𝐹𝑆𝑅  % ⋅ ℎ!! = △!!!!∙!   ∙ 100        (2) 
Where ΔEm is the change in bound 13C6 phenylalanine enrichment between two biopsy samples, Ep is the 
intracellular precursor enrichment and t is the time between muscle biopsies. 
 
4.3.7.2 Urea production 
The contribution of labelled urea infusion to endogenous production of urea was calculated 
as previously (16) described (equation 3). 
        (3) 
where i is the infusion rate of the urea tracer (µmol.h-1.kgBM-1) and Eup and Eui  are the enrichments of urea in the 
plasma and infusate respectively. 
 
4.3.7.3 Phenylalanine kinetics 
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Phenylalanine was chosen as the tracer as it is not oxidised in the muscle or synthesized in 
the body. Therefore new appearance of phenylalanine in the blood can be attributed to protein 
breakdown. Whole body phenylalanine appearance was calculated according to equation 4 
(43). 
          (4) 
where i is the infusion rate of the tracer (µmol.h-1.kgBM-1) and Ep is the enrichment of phenylalanine. 
 
Phenylalanine oxidation was calculated by using the phenylalanine balance model (40). 
Briefly, whole body phenylalanine oxidation (Qpt ) was determined from the calculation of the 
hydroxylation of L-[ring- 13C6]phenylalanine to L-[ring- 13C6]tyrosine using the equation 5 
(40). 
        (5) 
where Pt/Pp is estimated to be 0.73 (40). Qp is the phenylalanine flux  (µmol.h-1.kgBM-1), i is the infusion rate of 
the tracer (µmol.h-1.kgBM-1) and Ep and Et are the respective enrichments of phenylalanine and tyrosine.  
 
4.3.7.4 Area under the curve 
Area under the curve (AUC) has previously been used to detect differences in situations 
that have multiple time points (35). The benefit of using AUC is that the magnitude of 
response and changes over time are represented as a single number, irrespective of differing 
time intervals between measurements (11, 35).  Hence, calculation of AUC allows 
comparison between interventions of a physiologically interesting time frame.  
AUC for serum insulin concentrations and phenylalanine Ra and oxidation rates were 
calculated using Graphpad Prism V5.0 (Graphpad software incorporation, La Jolle, 
Ra =
i
Ep
Qpt =
Pt
Pp
•
Qp
2
Ep
Et
!1"
#
$
%
&
'• ip +Qp( )
Chapter 4: BCAA ingestion and MPS 
 101 
California, USA). Baseline values for insulin AUC were set at the concentration of insulin at 
t=0. A value of zero was used when calculating AUC for phenylalanine Ra and oxidation. 
4.3.8 Statistical analyses and data presentation 
Plasma concentrations were analysed using a two-way repeated measures analysis of 
variance (ANOVA). Exercise variables, FSR and AUC of serum insulin concentrations and 
phenylalanine kinetics for the post exercise period were analysed using a paired samples one-
tailed t-test. Western blot data are expressed as percentage change from t=0, and data were 
analysed using two way repeated measure ANOVAS. Significance for all analyses was set at 
P <0.05. Where significance was observed a least significant difference correction was used 
in post hoc analysis. All statistical tests were completed using statistical package for social 
sciences version 17.0 (Chicago, Illinois, USA). All values unless otherwise stated are 
presented as means ± standard error of the mean (SEM) unless otherwise stated. 
 
4.4 Results 
4.4.1 Exercise variables:  
There were no differences between conditions in the mass of lean tissue in the exercised 
leg (P >0.05). There were no between-trial differences in RPE or total exercise volume (P 
>0.05). An RPE of at least 19 was reached in all trials. Total exercise volume completed, 
including the warm up, was 11055±837 kg in BCAA and 11089±913 kg in PLA. 
4.4.2 Blood analytes 
Taken together urea concentrations significantly decreased in both drink conditions (main 
effect of time) towards the end of the recovery period. However no differences were observed 
between BCAA and PLA (Figure 4.2). 
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Figure 4.2: Plasma urea concentrations pre and post either a branched chain amino acid (BCAA) or 
placebo (PLA) beverage consumed following resistance exercise. 
 
There were no differences between BCAA and PLA in the production of urea (Figure 4.3). 
Taken together, urea production significantly decreased (main effect of time) from 
immediately post exercise to the end of the 4h recovery period.  
Figure 4.3: Urea production following either a branched chain amino acid (BCAA) or placebo (PLA) 
beverage consumed following resistance exercise. 
 
Glucose concentrations did not change over time and were not different between groups 
(Figure 4.4). Serum insulin concentrations increased in both trials following breakfast 
ingestion. There were no differences in serum insulin concentrations following drink 
ingestion (Figure 4.5). 
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Figure 4.4: Plasma glucose concentrations pre and post either a branched chain amino acid (BCAA) or 
placebo (PLA) beverage consumed following resistance exercise 
 
Figure 4.5: Serum insulin concentrations pre and post either a branched chain amino acid (BCAA) or 
placebo (PLA) beverage consumed following resistance exercise 
 
4.4.2.1 Amino acid concentrations 
Amino acid concentrations across time are shown in Figure 4.6. Branched chain amino 
acid concentrations were significantly higher following drink ingestion in BCAA than PLA. 
Peak branched chain amino acid concentrations were observed 30 min following drink 
ingestion. Plasma valine concentration increased 3-fold, isoleucine and leucine concentration 
increased 4-fold at 30 min following drink ingestion compared to basal. Threonine and 
phenylalanine concentrations were significantly increased post breakfast and decreased 
following the exercise. There were no differences in threonine concentrations between trials. 
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Phenylalanine concentrations were significantly higher towards the end of the recovery period 
in PLA compared to BCAA. 
 
Figure 4.6: Plasma concentrations of A) leucine, B) isoleucine, C) valine, D) threonine and E) 
phenylalanine both pre and following either a branched chain amino acid (BCAA) or placebo (PLA) 
beverage consumed following resistance exercise.  
* significant difference between trials 
 
4.4.2.2 Plasma 13C6 phenylalanine and tyrosine enrichments 
Plasma 13C6 phenylalanine enrichment was stable across the time of tracer incorporation, 
immediately post-exercise to 4 h post-exercise for BCAA and PLA (Figure 4.7). Plasma 13C6 
tyrosine enrichment increased throughout the testing period. Intracellular 13C6 phenylalanine 
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enrichment was stable across the time of tracer incorporation for BCAA and PLA (3.9 ± 0.2 
and 3.8 ± 0.2% t/T, respectively). Trial order did not influence the tracer enrichment in 
plasma or in intracellular samples. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: Plasma enrichment of 13C6 both pre and following either a branched chain amino acid (BCAA) 
or placebo (PLA) beverage consumed following resistance exercise. 
 
4.4.3 Phenylalanine kinetics 
No difference in phenylalanine Ra was detected over the 4 h recovery period (Figure 
4.8A). However, the overall phenylalanine Ra (AUC) was 6% (P =0.0028) lower in BCAA 
compared to PLA (Figure 4.8B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Phenylalanine rate of appearance following either a branched chain amino acid (BCAA) or 
placebo (PLA) beverage consumed following resistance exercise, depicted A) over time and B) as area 
under the curve.  
* significant difference between trials 
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There was a tendency (P =0.055) for a time by trial interaction for phenylalanine oxidation 
(Figure 4.9A). Additionally, AUC of phenylalanine oxidation was 16% (P =0.0006) lower in 
BCAA compared to PLA (Figure 4.9B).  
 
 
 
 
 
Figure 4.9: Phenylalanine oxidation following either a branched chain amino acid (BCAA) or placebo 
(PLA) beverage consumed following resistance exercise, depicted A) over time and B) as area under the 
curve.  
* significant difference between trials 
 
4.4.4 Anabolic signalling proteins 
There were no statistical differences between BCAA and PLA in the phosphorylation 
status of S6K1Ser421/Thr424, 4E-BP1Thr37, AKTThr308 or rpS6(Ser235/236) . When the trials were 
taken together there was a significant effect of time on the phosphorylation status of 
PRAS40Thr246 (P=0.025) (Figure 4.10). Additionally, the phosphorylation of AKT(Ser473) was 
significantly higher compared to immediately post drink at 60 min than 240 min. There was a 
strong tendency (P =0.058) in the phosphorylation status of (Figure 4.11), at 60 min. The 
phosphorylation of S6K1Thr389 in BCAA was 12 ± 6 % higher than PLA at 60 min post drink 
ingestion.  
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Figure 4.10: Percentage change from immediately post exercise in phosphorylation status (means ± SE) of 
PRAS40Thr246 60 and 240 min following either a branched chain amino acid (BCAA) or placebo (PLA) 
beverage consumed following resistance exercise.  
 
 
 
 
 
 
 
 
Figure 4.11: Percentage change from immediately post exercise in phosphorylation status (means ± SE) of 
S6K1Thr389 60 and 240 min following either a branched chain amino acid (BCAA) or placebo (PLA) 
beverage consumed following resistance exercise.  
 
 
4.4.5 Myofibrillar protein synthetic response 
Myofibrillar fractional synthetic rate (FSR) was ~22% greater (P =0.012) over the 4h 
recovery period in BCAA compared to PLA (Figure 4.12).  
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Figure 4.12: Fractional synthetic rate following either a branched chain amino acid (BCAA) or placebo 
(PLA) beverage consumed immediately following resistance exercise  
* significantly higher in BCAA 
 
4.5 DISCUSSION 
 
 The present study is the first to investigate the response of muscle myofibrillar protein 
synthesis to the ingestion of branched chain amino acids alone following resistance exercise 
with intake of a high protein breakfast. Our primary finding was that post-exercise 
myofibrillar muscle protein synthesis was greater with ingestion of a branched chain amino 
acid containing drink compared with a placebo. Additionally, the increased muscle protein 
synthesis was accompanied by a 12 % greater phosphorylation of S6K1Thr389. 
These data are the first to report that muscle protein synthesis can be increased following 
resistance exercise in trained human males with the ingestion of branched chain amino acids 
alone. Of all branched chain amino acids it is suggested that leucine is the most important as 
an anabolic agent. Studies that provided leucine plus protein (21, 22) observed no increase in 
muscle protein synthesis, when compared to protein alone. Furthermore, there was no greater 
anabolic response when leucine was added to whey protein (41). We provided only the 
branched chain amino acids and observed increases in synthesis above exercise alone. 
Therefore, taken together these data suggest that when muscle protein synthesis is already 
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stimulated with exercise and amino acids there is no further benefit of leucine. However, 
when only the branched chain amino acids are ingested muscle protein synthesis in increased 
above exercise alone.  
Ingestion of essential amino acids is known to increase muscle protein synthesis. The 
ingestion of as little as 5 g protein following exercise has been demonstrated to increase 
muscle protein synthesis above exercise alone (31). Furthermore, these authors (31) reported 
that 20 g of egg protein, containing 10 g EAA (4.3 g branched chain amino acids), maximally 
stimulated muscle protein synthesis. Thus, ingestion of 20g of whey protein may be classed as 
optimal to stimulate muscle protein synthesis. Previously when leucine has been co-ingested 
with both EAA (10 and ~ 21.7 g) (10, 14) and protein  (33.3 g) (22) there has been no further 
increase in muscle protein synthesis. However, in these studies (10, 14, 22) there was a 
greater than optimal amount of EAA or protein ingested. In situations where there are 
suboptimal (< 20 g protein) amounts of protein ingested muscle protein synthesis rates are 
lower (31). Therefore, muscle protein synthesis can be further increased. We demonstrated 
that branched chain amino acids ingestion alone increased muscle protein synthesis. In 
situations where there are suboptimal values of protein ingested it is unknown if additional 
branched chain amino acids would increase muscle protein synthesis. Thus, it would be 
interesting to investigate the effects of branched chain amino acids in combination with 
suboptimal levels of protein or essential amino acids. 
It is well known that ingestion of amino acids post exercise increases phosphorylation 
status of several signalling proteins (10, 13, 19). Leucine specifically is known to activate 
mTOR signalling cascade (1, 3, 7). Recently Karlsson et al. (17) demonstrated increased 
phosphorylation of S6K1Ser421/Thr424, S6K1Thr389 (~3.5 fold increase) and the downstream rpS6 
with branched chain amino acid ingestion and exercise compared to a placebo. In addition to 
Chapter 4: BCAA ingestion and MPS 
 110 
an augmentation of muscle protein synthesis we observed an ~ 5 fold increase above exercise 
in phosphorylation of S6K1Ser389 with branched chain amino acid ingestion. However, the data 
failed to reach statistical significance. Our results may lack statistical significance due to a 
lack of power, for most of the signalling proteins observed power < 0.05. The lack of 
statistical difference and low power could be attributed to a large inter-individual difference 
or the large differences in responses to branched chain amino acid ingestion. Our data suggest 
there to be a difference in the individual response of phosphorylation of signalling proteins to 
branched chain amino acid ingestion. This difference in response is prevalent in S6K1Thr389. 
The range in change of phosphorylation status between the two conditions over the first hour 
was ~2 – 50 arbitrary units. Therefore there are large changes between subjects in their 
response to branched chain amino acids. These data add to the growing body of evidence 
highlighting the differential response of signalling proteins in humans to anabolic stimuli, 
such as exercise and nutrition. 
The amount and feeding pattern of branched chain amino acids may influence 
phosphorylation status of signalling proteins. We saw a 12 % increase in phosphorylation 
status of S6K1Thr389 at 60 min post exercise. However, there were no differences in 
S6K1Thr421/Ser424 and rpS6 phosphorylation at 60 min post exercise. In contrast, Karlsson et al. 
(17) reported increases in S6K1Thr389, S6K1Thr421/Ser424 and rpS6 phosphorylation at 60 min 
and 120 min post exercise. The timing and amount of nutrient ingestion differed between the 
present study and Karlsson et al. (17). We provided 5.6 g of branched chain amino acids 
following resistance exercise. In contrast, Karlsson et al. (17) provided branched chain amino 
acids totalling ~ 7.4 g before during and after resistance exercise. The contrasting feeding 
pattern may have accounted for the different results in phosphorylation status of signalling 
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proteins between the current and previous study (17). Perhaps, more amino acids are required 
in regular doses to increase phosphorylation status of S6K1Thr421/Ser424 and rpS6. 
Feeding prior to exercise may minimise the chance of observing the effect of nutritional 
interventions following exercise. In the present study, we provided a high protein breakfast, to 
make our findings more practical. This breakfast may have altered the phosphorylation status 
of the signalling proteins. It is known that in humans following ingestion of protein the 
phosphorylation status of some signalling proteins remain elevated for > 3 h (4). If the 
phosphorylation status of signalling proteins had not returned to basal levels when the 
branched chain amino acids were ingestion, this could explain why there was not a difference 
between groups in the signalling proteins that we monitored. Therefore, the ingestion of 
breakfast may have masked any differences in phosphorylation status of signalling proteins 
between branched chain amino acid ingestion and placebo.  
Furthermore, the breakfast pre exercise may have reduced the effect of branched chain 
amino acids ingestion on muscle protein synthesis. Following resistance exercise, in a fasted 
state, protein ingestion increases muscle protein synthesis between ~35 and 90 % (20-22, 31, 
32, 38, 39). In the present study ingestion of amino acids increased muscle protein synthesis 
by ~22 % over a placebo. Qualitatively at least, our findings suggest that branched chain 
amino acids do not increase muscle protein synthesis to the same extent as complete or 
essential amino acid sources. However, feeding and high protein breakfast pre resistance 
exercise increases muscle protein synthesis above breakfast alone (47). Thus, muscle protein 
synthesis rates in the placebo condition of the present study may have been stimulated 
through a combination of the high protein breakfast and exercise. Therefore, the effect of 
ingesting branched chain amino acids on muscle protein synthesis may have been diminished 
through the ingestion of breakfast. At present it is unclear as to whether protein ingestion 
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stimulates muscle protein synthesis more than branched chain amino acids. Therefore, further 
studies are required to make a direct comparison between the effect of branched chain amino 
acid ingestion and protein on muscle protein synthesis. 
Leucine has been ingested in all previous studies that have reported increases in muscle 
protein synthesis with exercise and provision of amino acids. The importance of leucine also 
may be highlighted when the effects of whey and casein protein on muscle protein synthesis 
are compared. Whey protein has higher leucine content than casein. Ingestion of whey protein 
results in greater muscle protein synthesis than casein (34). It is suggested that the increase in 
blood leucine concentration needs to reach a threshold in order to reach a maximal rate of 
muscle protein synthesis.  Thus, the leucine content of casein is insufficient for blood leucine 
concentrations to reach this threshold. A recent study (46) compared whey protein supplied as 
a bolus ingestion or in small pulses. Total amount of amino acids and leucine ingested were 
the same in each condition. However, when the amino acids were given as 10 individual 
doses, the increase in synthesis was less than when a bolus of whey was ingested. Blood 
leucine concentrations peaked at a lower level with separated ingestion than bolus ingestion 
(46). The lower increase in blood leucine concentrations may have meant that blood leucine 
concentrations did not reach the threshold. Therefore, muscle protein synthesis was not 
increased as much with repeated ingestion compared to bolus ingestion. As may be expected 
with our higher dose of leucine provided in this study, our data show a greater peak in leucine 
concentrations than those observed by West and colleagues (46).  Hence, we suggest that 
perhaps the increase in plasma leucine concentrations we observed reached the threshold 
value. Therefore, the increase in plasma leucine concentrations we observed was important in 
our observation of increased muscle protein synthesis with branched chain amino acid 
ingestion. 
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Our data further support the suggested notion that the availability of leucine drives muscle 
protein synthesis. Many studies have suggested that leucine concentrations are important for 
muscle protein synthesis (9, 12, 18, 37, 39). In the present study when branched chain amino 
acids were ingested, there was a rapid rise in plasma leucine concentrations. Leucine 
concentrations were then elevated for 4 h of recovery. The rise in plasma leucine 
concentrations indicates an increased availability of leucine. Thus, the increase in muscle 
protein synthesis we observed with branched chain amino acid ingestion may have been 
partially caused by increased leucine availability. 
Infusion of leucine decreases protein degradation to a greater extent than a saline infusion 
(33). Furthermore proteolysis is suppressed with a branched chain amino acid infusion 
(25).However, the impact of branched chain amino acid ingestion, on muscle protein 
breakdown following resistance exercise, remains unknown. Muscle anabolism depends on 
both muscle protein synthesis and muscle protein breakdown. Leucine ingestion has been 
suggested to reduce muscle protein breakdown in resting conditions (33). However, protein 
containing an artificially increased leucine content did not influence net balance despite 
increasing the insulin response (14). To date no study has measured muscle protein 
breakdown following resistance exercise with the ingestion of branched chain amino acids 
only. In the present study we did not measure protein breakdown on a muscle level. However, 
we demonstrated a reduced whole body phenylalanine Ra and oxidation when branched chain 
amino acids were ingested, suggesting that whole body protein breakdown may be reduced. 
These findings are in line with Koopman et al. (22) who demonstrated that the ingestion of 
carbohydrate, protein and leucine resulted in a lower amino acid oxidation rate. The reduction 
in phenylalanine oxidation and Ra may suggest that ingesting branched chain amino acids 
results in amino acids being synthesised into proteins and not broken down. Our data suggest 
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that branched chain amino acids may have a role in reducing protein breakdown on a whole 
body level. However, it is unclear as to whether whole body measures are representative of 
what is happening in the muscle. Therefore future studies also should aim to investigate 
muscle protein breakdown, to determine a greater understanding of muscle anabolism with 
branched chain amino acid ingestion. 
Our urea production data show no differences between the two conditions, and therefore 
may suggest a lack of support for reduction in whole body protein breakdown with ingestion 
of branched chain amino acids. Ingestion of branched chain amino acids leads to an increase 
in ammonia (26-28). Whereas, not measured in the current study the lack of differences in 
urea production and urea concentrations between the two drink conditions suggest that 
ammonia concentration may not have increased with 5.6 g of branched chain amino acids. 
Our data may indicate that if proteins are being broken down the nitrogen is not being used 
for urea synthesis. Therefore, the nitrogen from amino acids may be used for synthesis of 
other nitrogen containing compounds. Thus, perhaps ingestion of branched chain amino acids 
perhaps maintains the nitrogen within body compounds. Hence, there was not an increase in 
urea production when branched chain amino acids were ingested. Alternatively the provision 
of the high protein breakfast may have caused a lack of difference between the two trial 
conditions. It is likely that some of the protein from the breakfast will be broken down, 
possibly creating urea, increasing urea production. This increase in urea production would 
have occurred in both trials. Thus, differences attributed to branched chain amino acid 
ingestion may be masked. 
In conclusion our results demonstrate that ingesting branched chain amino acids following 
a breakfast and resistance exercise increase myofibrillar muscle protein synthesis.  
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5.1 Summary and overview 
This thesis describes experiments that investigated the whole body and muscle response to 
ingestion of branched chain amino acids (BCAA) and protein following intense exercise. The 
aim of the first study (chapter 2) was to assess whether BCAA could reduce the negative 
symptoms that are associated with intense lengthening contractions. These negative indices 
included decreased muscle function, increased muscle soreness, inflammation and increased 
plasma concentration of myofibre proteins. The findings provide novel data for the current 
literature as it was demonstrated that BCAA was effective at reducing muscle soreness 
following intense lengthening contractions when compared to a placebo. However, there were 
no differences between BCAA and placebo ingestion regarding the decrement of 
maximalforce production, inflammation or myofibre protein concentration in the blood.  
The second study (chapter 3) in this thesis was designed to obtain further information 
about nutritional interventions aimed at reducing negative indices associated with muscle 
damage. In chapter 3 the same experimental approach as chapter 2 was adopted. However, a 
whey protein source, containing the same amount of BCAA, as in chapter 2 was compared to 
an isoenergetic control. The findings demonstrated that whey protein ingestion resulted in a 
reduced decrement in maximal muscle force production. Furthermore, whey protein ingestion 
had a likely beneficial effect, compared to an isoenergetic control, of attenuating the decrease 
in force production; however, whey protein ingestion did not ameliorate rises in inflammation 
or myofibre protein concentrations in the blood. 
The third study of this thesis (chapter 4) is the first study that has investigated muscle 
protein synthesis (MPS) with ingestion of only BCAA following resistance exercise. The 
main finding from this investigation was that ingestion of BCAA following resistance 
exercise increased rates of MPS.  
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5.2 Amino acid ingestion and eccentric exercise 
 
5.2.1 Summary 
Unaccustomed, exercise consisting of lengthening contractions leads to decreased maximal 
force production and range of motion and increased muscle soreness, plasma concentrations 
of myofibre proteins and inflammation. There has been much interest in the use of amino acid 
sources to alleviate these negative indices associated with lengthening contractions (10, 12-
14, 26, 37, 42, 44, 51). However, the results of these studies offer little agreement over the 
efficacy of amino acid sources to ameliorate the negative indices associated with lengthening 
contractions. Two studies (Chapters 2 and 3) from this thesis contribute novel data to this 
sector of literature. The same exercise protocol, supplementary pattern, and method of 
assessing recovery from the exercise bout were employed and most importantly diet was 
strictly controlled in both studies. Both whey protein and BCAA ingestion reduced muscle 
soreness following intense lengthening contractions. However, only whey protein ingestion 
resulted in an attenuated decrement in maximal force production. The mechanisms 
underpinning the reduction in soreness and attenuation of force production decrements with 
nutritional interventions remain unclear. 
The dose of amino acids may be important for reductions in negative indices associated 
with lengthening contractions. In chapter 2 we provided 7.3 g of BCAA in each dose as four 
doses per day for 3 d totalling 87.6 g. A more recent study by Kirby and colleagues (26) 
provided 250 mg/kg body mass, which equated to ~ 19 g BCAA within each dose. Kirby et al 
(26) provided supplements pre and post exercise and the in the morning of the following day 
so total leucine ingestion was ~57 g. However, taken together, differences in experimental 
design in addition to the amount of BCAA ingested do not allow a direct comparison between 
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the outcomes. Kirby et al. (26), provided more leucine but less amino acids than the 
experiment described in chapter 2. Leucine ingestion resulted in a better maintenance of force 
production compared to the control group (26). Therefore when taken together, these data 
support the notion that perhaps when consuming leucine or the BCAA, a bigger dose at the 
start of the day results in better maintenance of strength. Alternatively, smaller boluses 
throughout the day reduce muscle soreness.  
5.2.1.1 Muscle soreness and function 
Habitual movement may help to reduce muscle soreness. In both studies (chapter 2 and 3) 
indices of muscle soreness were assessed 8 h following the exercise bout. Interestingly 
soreness was lower in all four groups at 8 h compared with 1 h post exercise. Two factors 
make this time point unique in relation to the other time points we chose in the study design. 
First, the 8 h time point is measured with the volunteers in a post-prandial/fed state. 
Therefore, it is possible that feeding can influence subjective feelings of soreness. However, 
the 8 h measurement was completed when the subjects had been weight bearing and 
completing light exercise on the exercised muscle. In contrast, the morning measurements 
were taken in a situation after the exercised leg muscle had not been moved for approximately 
8 h. Light exercise has been shown to be effective in reducing symptoms commonly 
associated with muscle damage (5).  Therefore, performing activities of daily living may be 
effective at reducing muscle soreness. Thus, decrease in muscle soreness at 8 h may be 
attributed to daily exercise.   
There is a difference in the temporal pattern of soreness and muscle function between 
ingesting BCAA (chapter 2) and whey protein (chapter 3) pre and post exercise. In chapter 2 
when only BCAA were ingested, reductions in muscle soreness were reported at 48 h and 72 
h post exercise compared with placebo. In contrast, ingestion of whey protein reduced muscle 
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soreness only within the first 24 h following the exercise protocol compared to carbohydrate 
ingestion. Furthermore, from 24 -72 h post exercise onwards soreness scores reported with 
carbohydrate and whey protein ingestion were similar. Additionally, BCAA ingestion did not 
impact muscle function (low frequency fatigue or maximal isometric strength), however whey 
protein ingestion resulted in reductions in the decrements of maximal force production 
compared to carbohydrate. Thus, it appears that whey protein ingestion only affects the initial 
24 h period and fails to ameliorate feelings of soreness or decrements in maximal muscle 
force production thereafter.  
On the other hand the isoenergetic control (i.e. the carbohydrate) may influence the 
observed findings, hence, making the temporal pattern of BCAA and whey protein effect 
appear different. The same experimental design was implemented in both experiments, thus, 
permitting a direct comparison of the data from all four groups. Comparison of the complete 
recovery period is shown in Figure 5.1. Whey protein and BCAA ingestion results in similar 
muscle soreness over the whole recovery period. Carbohydrate ingestion results in the largest 
initial increase in muscle soreness scores post exercise and then decreased to similar scores as 
both whey protein and BCAA ingestion. Ingestion of the flavoured water placebo resulted in 
higher soreness scores than BCAA, carbohydrate and placebo ingestion towards the end of the 
recovery period. Thus, our results suggest that perhaps early in the post exercise period 
carbohydrate has a negative impact on feelings of muscle soreness. However, in the later part 
of recovery whey protein, BCAA and carbohydrate are effective at reducing muscle soreness. 
Therefore, it would appear that whey protein actually has the same temporal pattern as BCAA 
when compared to the same control condition. 
.   
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Figure 5.1: Muscle soreness shown as A) raw values and B) area under the curve of flexed muscle soreness 
over the entire 72 h period. 
Data are expressed as means ± SE. Supplements were consumed 12 times over the testing period and contained 
branched chain amino acids (BCAA), placebo (PLA), whey protein (WP) or carbohydrate (CHO).  
 
Resistance exercise, particularly lengthening contractions, results in the deformation of the 
proteins responsible for maintaining the structural integrity of the skeletal muscle architecture. 
The findings in this thesis suggest all amino acids are required for recovery of maximal 
muscle force production. Chapter 2 demonstrated that ingestion of BCAA had no effect on 
maximal muscle force production. However, the ingestion of whey protein when compared to 
a carbohydrate control, showed a likely beneficial effect on minimising the loss in maximal 
muscle force production, although the significance of this is questionable as this reduction in 
force production was apparent only over the first few hours. 
The control condition may affect the interpretation of results. As with muscle soreness the 
results of maximal force production can be combined (Figure 5.2). There is a likely 
detrimental effect of carbohydrate compared to whey protein, BCAA and flavoured water 1 h 
post exercise. However, when comparing between supplements at the end of the recovery 
period there is a likely beneficial effect of both carbohydrate and whey protein compared with 
BCAA and the flavoured water placebo. In chapter 3 when carbohydrate and whey protein are 
compared there is no effect on maximal isometric strength at the end of the experimental 
period. However, when compared to a flavoured water placebo there is an effect at reducing 
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the decrements in maximal force production with whey protein ingestion. Therefore, these 
data further support the importance of drawing conclusions about nutritional interventions 
when differing control conditions are employed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Muscle function shown percentage force loss over the entire 72 h period.   
Data are expressed as means ± SE. Supplements were consumed 12 times over the testing period and contained 
branched chain amino acids (BCAA), placebo (PLA), whey protein (WP) or carbohydrate (CHO) 
 
5.2.1.2 Future studies 
If comparisons between nutritional conditions are being investigated, extrinsic factors, 
such as diet, should be strictly controlled to avoid confounding results. Therefore, future 
studies should aim to strictly control diet. Diets should be controlled so that the energy intake 
matches the individual’s habitual intake, thus ensuring subjects remain in energy balance 
during the testing period. 
There appears to be a difference in how male and females respond to nutritional 
interventions following lengthening contractions. There is only one study (42) that has 
investigated the impact of nutritional interventions following lengthening contractions in 
females. This study (42) investigated females since the authors’ preliminary study (43) had 
demonstrated the effect of supplementation was more pronounced in females compared to 
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males. Thus, further work should investigate these potential sex differences in effectiveness of 
supplementation following intense resistance exercise.  
The beneficial effects of exercise on human health have been widely explored. However, 
as we have demonstrated, an unaccustomed exercise bout is often accompanied by negative 
symptoms, including muscle soreness, decreased muscle function and possibly inflammation. 
Recommendations have suggested that aged individuals should adopt exercise programmes to 
allow them to live a healthy, independent and greatly improved quality of life (32). 
Unaccustomed exercise can be related to an unaccustomed length of the muscle, 
unaccustomed number of repetitions or unaccustomed forces (45). Aged individuals that start 
an exercise programme are likely to experience symptoms similar to those reported in 
chapters 2 and 3. Therefore, it may be useful if nutritional and dietary interventions are 
developed to reduce the negative indices associated with skeletal muscle damage for 
individuals to ingest after their first few exercising sessions. The nutritional effects on the 
negative indices associated with lengthening contractions is yet to be elucidated in aged 
individuals. It may therefore be interesting to see if supplementation of BCAA or whey 
protein reduces these negative symptoms especially that of muscle function and muscle 
soreness in an aged population. Thus, future studies should investigate the response of BCAA 
or whey protein following multiple lengthening contractions in aged individuals. 
In chapters 2 and 3 we measured interleukin 6 (IL-6) as a marker of inflammation. 
However it may not have been the most suitable in response to the lengthening contractions as 
elevated levels are observed after many exercise modalities. The inflammatory response can 
be described as acute or prolonged, and relate to a muscle or whole body level. IL-6 and pre 
albumin have been shown to increase and return to baseline levels following a long distance 
triathlon (21). However, levels of C-reactive protein increased gradually after exercise 
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cessation and were at the peak values measured 16 h after exercise cessation (21). Thus, it 
may be interesting to measure the effect of whey protein and BCAA ingestion on other 
inflammatory markers which have a more delayed response following lengthening 
contractions. Additionally, the use of magnetic resonance imaging to monitor swelling and or 
oedema may also assist in understanding what is happening in the muscle when nutritional 
interventions are provided as a method to alleviate symptoms associated with lengthening 
contractions. 
Muscle damage has been associated with whole body and myofibrillar protein breakdown 
(16, 17). Furthermore, animal studies indicate that damaging exercise increases muscle 
protein breakdown (MPB) and transiently decreases MPS resulting in loss of muscle proteins, 
particularly the force-generating myofibrillar proteins (20, 31). Myofibrillar protein synthesis 
was shown to be elevated at 8.5 h following damaging exercise in humans (34), but MPB was 
not examined. Furthermore, these measures were made shortly (up to 8.5h) following exercise 
and no study has examined later time points in humans as has been done in rats. Thus, no 
systematic examination of protein metabolism associated with muscle damage in humans has 
yet been made. Therefore, it would be of interest to quantify MPS and MPB in response to 
damaging exercise. It is important to know what happens to MPS and MPB as well as net 
protein synthesis to develop feeding strategies that optimise net protein synthesis and improve 
recovery from damaging exercise. 
 
5.3 Branched chain amino acid ingestion and muscle protein synthesis 
 
5.3.1 Summary 
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Resistance exercise combined with ingestion of BCAA increases myofibrillar MPS. 
Exercise of sufficient intensity (30) is known to stimulate mixed MPS in young healthy 
males. Ingestion of amino acids is required for a positive net balance, resulting in muscle 
mass gain (7, 40, 50). In a fasted state, the combined effect of nutrition and exercise to 
stimulate MPS is well established (7, 9, 15, 19, 28, 29, 35, 38, 40, 46-50). However, many 
athletes will consume a meal prior to their workout and an amino acid source following their 
exercise session. However, no study had investigated the combined effect of two nutritional 
interventions (meal before and amino acid source post) with resistance exercise. Therefore in 
chapter 4 we provided a high protein breakfast prior to the exercise bout. Following exercise 
BCAA or a placebo beverage was provided. We demonstrated that myofibrillar MPS could be 
increased in a postprandial state with the ingestion of BCAA. 
The control condition may influence the outcome of the experiment. In chapter 4 the 
subjects were provided with a breakfast. The combination of exercise and breakfast has 
previously been shown to increase MPS more than feeding alone (53). Thus, the MPS rates in 
the placebo condition (feeding and exercise) potentially were elevated above those commonly 
reported with exercise alone. Therefore, the relatively small difference in MPS between 
placebo and BCAA in chapter 4 may be explained by the elevated MPS in the placebo 
condition. It may be difficult to compare the effect of interventions between studies that have 
a different control condition. For example Moore et al. (36) showed an ~93% increase in MPS 
comparing an exercised leg with an exercised leg and the ingestion of 25 g egg protein. The 
comparison in this study (36) was between an exercised and an exercised-fed situation. 
Consequently, until a study has made a direct comparison between the ingestion of protein 
and BCAA, it is unknown which nutritional intervention would result in higher MPS rates. 
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There are many signalling proteins that control both transcription and translation. The 
phosphorylation status of some signalling proteins were measured in chapter 4 when either a 
placebo or 5.6 g of BCAA were ingested following resistance exercise. We observed a strong 
tendency for higher phosphorylation of S6K1Thr389 at 60 min with BCAA ingestion following 
exercise. This is consistent with observations by Karlsson et al (22). However, these authors 
(22) also observed differences in phosphorylation status of S6K1Thr421/Ser424 and rpS6 with 
BCAA ingestion and resistance exercise compared with exercise alone. These authors (22) 
provided BCAA before, during and after exercise totalling ~7.4 mg. Therefore a greater 
amount of BCAA were ingested in Karlsson et al. (22) than our study in chapter 4. This 
ingestion of greater amounts of BCAA may have been a reason for the discrepancies observed 
in signalling. Alternatively, the inconsistencies in the findings between the two studies could 
be attributed to various the feeding strategies employed, including bolus vs frequent feeding. 
On the other hand contradicting conclusions between the results in chapter 4 and Karlsson et 
al. (22) may be due to wide variations in the measurements of signalling proteins. It is 
important to note that current methods to assess phosphorylation status of signalling proteins 
are highly qualitative. Furthermore, phosphorylation of a protein only represents one form of 
activation for review see Kimball et al. (24).  
Similarly to results of MPS, the phosphorylation status of signalling proteins may have 
been influenced by the breakfast we provided. It is known that in humans following ingestion 
of protein the phosphorylation status of some signalling proteins remain elevated for > 3 h (6).  
Furthermore, the synergistic effect of exercise and nutrition on S6K1Thr389 has been shown to 
occur 5 h post protein ingestion (33). The 1 h biopsy in chapter 4 was 5 h post ingestion of the 
high protein breakfast. Therefore the phosphorylation status may have been elevated in both 
conditions at 1 h due to the combined effect of the breakfast and the exercise. Hence we 
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observed no difference in phosphorylation status of S6K1Thr389 when the BCAA were ingested 
compared to the placebo condition. The elevation in phosphorylation status of signalling 
proteins from the breakfast may have minimised the chance of observing an effect of BCAA 
ingestion. Hence, our results showing no difference between the conditions in 
phosphorylation status of the measured signalling proteins. 
 
5.3.2 Future studies 
Of interest to many exercisers is the dose of protein that is required to maximally stimulate 
MPS. Two studies investigating the ingestion of egg (35) and whey (52) protein have 
demonstrated that 20 g of protein maximally stimulates MPS. This equates to ~ 4.3 - 4.6 g of 
BCAA, which is less than was used in chapter 4. In chapter 4 it was demonstrated that 5.6 g 
BCAA were all that was required to stimulate MPS. If only the BCAA are required for 
increases in MPS it would be of interest to investigate the dose response of BCAA alone. 
There is no effect on MPS or muscle anabolism of ingesting leucine plus either protein (28, 
29, 49) or essential amino acids (EAA) at rest or following exercise when compared to protein 
/ EAA only (19, 28, 29, 49). When a difference in MPS has been observed with ingestion of 
leucine and an amino acid source ingestion the control group does not ingest protein / EAA, 
thus the effect of the leucine is difficult to determine from the protein (15, 18, 27). Previous 
studies have suggested that 20 g protein is optimal to maximally stimulate MPS following 
resistance exercise (35, 52). In the studies that have investigated leucine plus amino acid 
sources >20 g protein or amino acids were ingested. Therefore, it seems that when leucine has 
been co-ingested with protein and EAA there have been optimal amounts of protein / EAA 
ingested. Thus, MPS may not have been increased with the addition of leucine since the rate 
of MPS was already maximised due to the protein / EAA ingestion. No study has combined 
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doses of protein that may be classed as suboptimal (< 20 g protein) and additional leucine. 
Thus, based on the findings in chapter 4, that BCAA can stimulate MPS, it may be interesting 
to combine BCAA and suboptimal amounts of protein / EAA. The combination of protein and 
leucine may result in increases in MPS and phosphorylation status of signalling proteins.  
Of all three BCAA, leucine has received the most attention as an anabolic stimulus in rats 
(1, 2). Recent studies have suggested that the availability of leucine is important (11, 18, 25, 
41, 47).  Furthermore, studies have shown that ingestion of leucine up regulates signalling 
proteins (3, 8, 15).  However, in humans the effect on MPS of ingesting leucine alone has 
never been investigated. Thus, a study that would add further information to the current 
thoughts on the requirements for leucine would be to investigate the effect on MPS of 
providing only leucine. If successful, the dose that provides a maximal protein synthetic rate 
could be sought. 
A recent study combined the ingestion of carbohydrate, protein and leucine (28). These 
authors (28) suggested that the extra leucine would increase phosphorylation of signalling 
proteins and therefore increase MPS. These authors (27, 28) found no further increase in MPS 
with the additional leucine than when compared to protein and carbohydrate alone, and there 
were no differences in the response between young and aged. Furthermore, a study completed 
by the same research group (27) observed no difference in the response of protein plus leucine 
on MPS following exercise. Conversely, Katsanos et al. (23) demonstrated greater MPS in 
elderly at rest when an EAA mixture was enriched to 41 % leucine. When providing BCAA 
post exercise we observed a greater increase in MPS than exercise alone (chapter 4). To date 
no study has investigated the effect of BCAA and exercise in the elderly. Therefore, it would 
be of interest to investigate if the effect of BCAA on MPS would be present in an aged 
population.  
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During prolonged exercise the muscle may become catabolic. MPS is reduced in rats 
following prolonged exercise (2). Leucine has been shown to restore MPS back to baseline 
levels following exercise that resulted in decreased MPS (2, 25). The restoration of MPS was 
associated with a restoration of intracellular signalling leading to enhanced translation 
initiation (2, 4, 25). These data suggest that leucine (BCAA) may have a greater impact on 
muscle during catabolic situations, such as prolonged, intense exercise. In chapter 4 we 
demonstrated that BCAA increased MPS during an anabolic situation. A future study could be 
designed to investigate the effect of BCAA or leucine on MPS following prolonged intense 
exercise. 
As previously discussed the breakfast that was provided in chapter 4 may have had an 
influence on the phosphorylation status of the signalling proteins and MPS. However, with 
the experimental design implemented in chapter 4 it was not possible to determine if the 
breakfast influenced our findings. Therefore, a future study could be designed to compare the 
effect of BCAA ingestion and resistance exercise on MPS and phosphorylation status of 
intracellular signalling proteins with and without the provision of a breakfast. 
The exact mechanisms that orchestrate molecular signalling activity are yet to be fully 
elucidated. Although there has been a great deal of work completed in rodent models, the 
exact time course for signalling protein in humans has only recently been investigated (6, 33). 
Atherton and colleagues (6) demonstrated a disconnect between changes in phosphorylation 
status of signalling proteins and changes in MPS. The peak in MPS was observed ~ 90 min 
after ingestion of a high dose (48 g) of whey protein (6). The phosphorylation status of 
signalling proteins matched the increase in synthesis, however as the rate of synthesis 
declined there was little change in the phosphorylation status of the cell. Therefore, the 
change in phosphorylation status of signalling proteins has a longer duration than the increase 
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in synthesis. Conversely, the phosphorylation of S6K1Thr389 has been shown to follow a 
similar pattern to MPS after resistance exercise and ingestion of 25 g of whey protein. If the 
peak in phosphorylation of signalling proteins is at 90 min post drink ingestion we may have 
missed the peak in phosphorylation of signalling proteins. However, it should be noted that 
the peak at 90 min in phosphorylation status was observed in a rested situation (6). Exercise 
alone can increase mTOR related signalling proteins (39). As the present study included 
exercise the combined stimulus of exercise and BCAA ingestion may have altered the time 
course of phosphorylation of mTOR related signalling proteins. Further work should 
investigate the time course of signalling proteins phosphorylation alongside MPS following 
exercise and amino acid ingestion. 
 
5.4 Summary and Conclusions 
The data from this thesis point towards current thoughts that BCAA are important, but may 
not be all that is needed for complete recovery. We have shown in untrained males that 
BCAA reduces muscle soreness, but not muscle function, following multiple lengthening 
contractions. However both muscle function and muscle soreness are reduced with whey 
protein ingestion. BCAA ingestion in trained males increases MPS rates, however perhaps not 
to the same extent as essential amino acids (EAA) or protein.  
• BCAA ingestion reduces muscle soreness in untrained subjects following a bout of 
intense lengthening contractions. 
• Whey protein reduces muscle soreness and results in reduced decrements in muscle 
function in untrained subjects following a bout of lengthening contractions. 
• BCAA ingestion increases MPS following resistance exercise. 
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The data from this thesis suggest that BCAA have a role in recovery from damaging 
exercise and the growth of myofibrillar tissues. 
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Appendix A 
 
School of sport and exercise sciences 
 
Consent form 
 
 
 
Investigation; Effect of ingestion of an amino acid source on muscle function and 
markers of muscle damage and soreness. 
 
 
Investigators:  Dr Kevin Tipton, Mr Oliver Witard, Miss Sarah Jackman,  
 
Subject Number: 
 
 
Name:  
 
 
Address:  
 
 
DOB: 
 
 
 
I have read the attached information sheet and discussed the investigation with 
………. ………….who has explained the procedures to my satisfaction.  I am willing 
to undergo the investigation but understand that I am free to withdraw at any time 
without having to give an explanation and that doing so will not affect my treatment or 
care I receive 
 
 
Signed……………. 
 
Witnessed………….. 
 
Date……………. 
Appendix B 
 
The University of Birmingham 
School of Sport and Exercise Sciences 
General Health Questionnaire 
 
Name:  .................................................................................... 
Address: .................................................................................... 
  .................................................................................... 
  .................................................................................... 
Phone: .................................................................................... 
 
Name of the responsible investigator for the study: 
 
  ................................................................................... 
Please answer the following questions.  If you have any doubts or difficulty with the 
questions, please ask the investigator for guidance.  These questions are to determine 
whether the proposed exercise is appropriate for you.  Your answers will be kept strictly 
confidential. 1.  You are.......  Male  Female 2.  What is your exact date of birth?   Day........... Month...........Year..19........ So your age is........................... Years 
   
3.  When did you last see your doctor?     In the: Last week............ Last month.......... Last six months............ Year................. More than a year........... 
   
4.  Are you currently taking any medication?  YES  NO 5.  Has your doctor ever advised you not to take vigorous exercise?  YES  NO 6.  Has your doctor ever said you have “heart trouble”?  YES  NO 7.  Has your doctor ever said you have high blood pressure?  YES  NO 8.  Have you ever taken medication for blood pressure or your heart?  YES  NO 9.  Do you feel pain in your chest when you undertake physical activity?  YES  NO 10.  In the last month have you had pains in your chest when not doing any physical activity?   YES   NO 11.  Has your doctor (or anyone else) said that you have a raised blood cholesterol?   YES   NO 
Appendix B 
 
12.  Have you had a cold or feverish illness in the last month?  YES  NO 13.  Do you ever lose balance because of dizziness, or do you ever lose consciousness?  YES  NO 14.  a) Do you suffer from back pain b)  if so, does it ever prevent you from exercising?  YES YES  NO NO 15.  Do you suffer from asthma?  YES  NO 16.  Do you have any joint or bone problems which may be made worse by exercise?  YES  NO 17.  Has your doctor ever said you have diabetes?  YES  NO 18.  Have you ever had viral hepatitis?  YES  NO 19.  If you are female, to your knowledge, are you pregnant?  YES  NO 20.   Do you know of any reason, not mentioned above, why you should not exercise?  YES  NO 21.  Are you accustomed to vigorous exercise (an hour or so a week)?  YES  NO 
 
I have completed the questionnaire to the best of my knowledge and any questions I had 
have been answered to my full satisfaction. 
 
Signed: .............................................................   
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Study Number:  
 
Patient Identification Number for this trial:  
 
 
CONSENT FORM  
 
Title of Project: ‘Effects of branched chain amino acid supplementation on post- exercise 
muscle protein metabolism’ 
 
Name of Researcher:  
Please 
initial box  
 
1. I confirm that I have read and understand the information sheet 
dated....................  
(version............) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected.  
 
3. I understand that relevant sections of my medical notes and data collected 
during the study, may be looked at by individuals from GlaxsoSmithKline, from 
regulatory authorities or from the NHS Trust, where it is relevant to my taking 
part in this research. I give permission for these individuals to have access to my 
records.  
 
4. I agree to my GP being informed of my participation in the study.  
 
5. I agree to take part in the above study.  
 
 
 
 
 
Name of participant    Date    Signature  
 
 
 
 
 
 
Name of Person taking consent  Date    Signature 
 
 
